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Precise gene regulation is essential for a wide variety of transient, developmen-
tal, and homeostatic processes. The majority of gene regulation is mediated by
cis-regulatory elements, both distal (enhancers), and proximal (promoters & en-
hancers). Developments in biochemical assays, gene editing techniques, and
sequencing technology have enabled genome-wide profiling of regulatory ele-
ments over a wide variety of in vivo conditions. In this tripartite work, I present
separate statistical frameworks for analyzing how these repertoires of regula-
tory elements work at both physiological, and evolutionary timescales.
The first part describes the use of PRO-seq to characterize rapid changes
in the transcriptional landscape of human cells to celastrol, a compound that
has potent anti-inflammatory, tumor-inhibitory, and obesity-controlling effects.
By exploiting the ability of PRO-seq to detect nascent RNAs, I characterize the
transcriptional response at both genes and enhancers, and leverage statistical
models to detect transcription factors that orchestrate it. I implicate several tran-
scription factors in early transcriptional changes, including members of the E2F
and RFX families. PRO-seq also allows us to detect an increase in transcription
start site proximal pausing, suggesting that pause release may be a mechanism
for inhibiting gene expression during the celastrol response. This work demon-
strates that a thorough analysis of PRO-seq time-course data can provide novel
insight into multiple aspects of a complex transcriptional response.
The second part develops a statistical model for determining whether con-
stituent enhancers of a “super-enhancer” exhibit synergy and thus address the
question “Is a super-enhancer greater than the sum of its parts?” In this work
I reconcile two works with seemingly opposing theses by finding that we can-
not confidently reject synergy-free models for super-enhancers. Furthermore, I
demonstrate that thoughtful consideration of null models for synergy in gene
regulation is critical for furthering our understanding of ensembles of regula-
tory elements.
In the final section, I develop evolutionary models for cis-regulatory func-
tion as quantified by genome-wide biochemical assays. I apply a noise-aware
phylogenetic model to analyze the evolution of H3K27Ac and H3K4me3 his-
tone marks as proxies of enhancer and promoter function. I estimate relative
turnover rates for a variety of functional element categories and show that gene
expression and sequence constraint correlate with turnover rate. I also propose
that dosage sensitivity of target genes can explain the discrepancy between se-
quence and histone mark turnover rates of associated CREs.
This work illustrates the important role statistical models play in under-
standing gene regulation at all levels and suggests a potential path towards
unified models of gene regulation and evolution.
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CHAPTER 1
NASCENT RNA SEQUENCING REVEALS A DYNAMIC GLOBAL
TRANSCRIPTIONAL RESPONSE AT GENES AND ENHANCERS TO THE
NATURAL MEDICINAL COMPOUND CELASTROL
Note: With the exception of a few minor changes, this chapter contains the
same text as the previously published work “Nascent RNA sequencing reveals
a dynamic global transcriptional response at genes and enhancers to the natural
medicinal compound celastrol” in Genome Research (Volume 27, Number 11).
1.1 Abstract
Most studies of responses to transcriptional stimuli measure changes in cellu-
lar mRNA concentrations. By sequencing nascent RNA instead, it is possible
to detect changes in transcription in minutes rather than hours, and thereby
distinguish primary from secondary responses to regulatory signals. Here, we
describe the use of PRO-seq to characterize the immediate transcriptional re-
sponse in human cells to celastrol, a compound derived from traditional Chi-
nese medicine that has potent anti-inflammatory, tumor-inhibitory, and obesity-
controlling effects. Celastrol is known to elicit a cellular stress response resem-
bling the response to heat shock, but the transcriptional basis of this response
remains unclear. Our analysis of PRO-seq data for K562 cells reveals dramatic
transcriptional effects soon after celastrol treatment at a broad collection of both
coding and noncoding transcription units. This transcriptional response oc-
curred in two major waves, one within 10 minutes, and a second 40-60 min-
utes after treatment. Transcriptional activity was generally repressed by celas-
trol, but one distinct group of genes, enriched for roles in the heat-shock re-
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sponse, displayed strong activation. Using a regression approach, we identified
key transcription factors that appear to drive these transcriptional responses,
including members of the E2F and RFX families. We also found sequence-
based evidence that particular TFs drive the activation of enhancers. We ob-
served increased polymerase pausing at both genes and enhancers, suggesting
that pause release may be widely inhibited during the celastrol response. Our
study demonstrates that a careful analysis of PRO-seq time-course data can dis-
entangle key aspects of a complex transcriptional response, and it provides new
insights into the activity of a powerful pharmacological agent.
1.2 Introduction
The technique of perturbing cells and then measuring changes in their patterns
of gene expression is a reliable and widely used approach for revealing mecha-
nisms of homeostatic regulation. In mammalian cells, a wide variety of stimuli
that induce striking changes in transcription are routinely applied, including
heat shock, hormones such as estrogen, androgen and cortisol, lipopolysaccha-
ride, and various drugs. Regardless of the stimulus, transcription is commonly
assayed by measuring concentrations of mature mRNA molecules, typically us-
ing RNA-seq. This approach is now relatively straightforward and inexpensive,
and allows for the use of standard analysis tools in detecting many transcrip-
tional responses(Oshlack et al., 2010; Ozsolak and Milos, 2011).
Nevertheless, these mRNA-based approaches are fundamentally limited in
temporal resolution owing to the substantial lag between changes in transcrip-
tional activity and detectable changes in the level of mRNAs. This lag results in
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part from the time required for transcription and post-transcriptional process-
ing, and in part because pre-existing mRNAs buffer changes in mRNA concen-
tration. For a typical mammalian gene, significant changes may require hours
to detect, making it difficult to distinguish primary responses to a signal from
secondary regulatory events. A possible remedy for this limitation is instead to
make use of GRO-seq (Core et al., 2008), PRO-seq (Kwak et al., 2013), NET-seq
(Churchman and Weissman, 2011; Mayer et al., 2015; Nojima et al., 2015), or re-
lated methods (Dolken et al., 2008; Rabani et al., 2011; Li et al., 2016) for assaying
nascent RNAs. These assays have the important advantage of directly measur-
ing the production of new RNAs, rather than concentrations of mature mRNAs.
As a consequence, they can detect immediate changes in transcriptional activ-
ity, and they permit time courses with resolutions on the order of minutes rather
than hours (Danko et al., 2013; Hah et al., 2011; Jonkers et al., 2014; Mahat et al.,
2016). An additional benefit of nascent RNA sequencing is that it is effective
in detecting unstable noncoding RNAs, including enhancer RNAs (eRNAs), to-
gether with protein-coding transcription units (Hah et al., 2011, 2013; Core et al.,
2014). As a result, both active regulatory elements (which are generally well
marked by eRNAs) and transcriptional responses can be detected using a single
assay (Danko et al., 2015).
In this study, we sought to use PRO-seq to characterize the immediate,
dynamic transcriptional response to the compound celastrol. Celastrol (also
known as tripterine) is a pentacyclic triterpenoid isolated from the root extracts
of Tripterygium wilfordii (thunder god vine), which has been used for millen-
nia in traditional Chinese medicine for treatment of fever, joint pain, rheumatoid
arthritis, bacterial infection, and other ailments (Westerheide et al., 2004). Dur-
ing the past few decades, celastrol has shown promise as an anti-inflammatory
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agent in animal models of collagen-induced arthritis, Alzheimer’s disease,
asthma, systemic lupus erythematosus, and rheumatoid arthritis (Guo et al.,
1981; Allison et al., 2001; Xu et al., 2003; Li et al., 2005; Sethi et al., 2007). In
addition, celastrol is known to inhibit the proliferation of tumor cells, including
those from leukemia, gliomas, prostate, and head/neck cancer (Sethi et al., 2007;
Nagase et al., 2003; Yang et al., 2006; Fribley et al., 2015). Recent research has
also demonstrated striking obesity-controlling effects in mice (Liu et al., 2015;
Ma et al., 2015).
Celastrol is known to activate the mammalian heat shock transcription fac-
tor HSF1 and stimulate the heat shock response(Westerheide et al., 2004; Trott
et al., 2008) as well as the unfolded protein response (Fribley et al., 2015; Mu
et al., 2008). In addition, celastrol activates a battery of antioxidant response
genes (Trott et al., 2008). At the same time, celastrol inhibits the activities of
other transcription factors, including androgen receptor (Hieronymus et al.,
2006), glucocorticoid receptor (Trott et al., 2008) and NF-KB (Sethi et al., 2007).
Thus, in several respects, the cellular response to celastrol resembles other well-
known stress responses, including, in particular, the response to heat shock.
Indeed, this heat-shock-like behavior appears to explain, in part, the cytopro-
tective properties of celastrol. Nevertheless, it remains unclear exactly what
distinguishes the celastrol response from heat shock and other stress responses.
In particular, little is known about the immediate transcriptional effects or pri-
mary targets of celastrol. Thus, an examination using PRO-seq provides an op-
portunity for a deeper understanding of the specific mechanisms underlying
the activity of this potent compound, with potential therapeutic implications.
With these goals in mind, we collected PRO-seq data for K562 cells at tightly
4
spaced time points after treatment with celastrol and analyzed these data us-
ing a variety of computational methods. Our analysis sheds new light on the
immediate transcriptional response to celastrol at both regulatory elements and
target genes. More generally, it demonstrates that time-courses of PRO-seq data
together with appropriate bioinformatic analyses can be used to dissect key as-
pects of a complex transcriptional response.
1.3 Results
1.3.1 Celastrol induces broad transcriptional repression and
more limited up-regulation
We prepared PRO-seq libraries for K562 cells before celastrol treatment and af-
ter 10, 20, 40, 60, and 160 minutes of celastrol treatment, with two biological
replicates per time point (Figure 1.1A). To ensure that we could normalize read
counts even in the presence of global changes in transcription, we spiked the
same number of permeable Drosophila cells into each sample prior to run-
on (Booth et al. 2016). Samples were sequenced to a total combined depth
of 334.3M reads, with an average replicate concordance of r2 = 98% (Supple-
mental Figure 1.8). About 0.5M of these reads (0.1%) were derived from the
Drosophila spike in. To obtain gene models appropriate for our cell types and
conditions, we developed a probabilistic method, called tuSelector, that con-
siders all GENCODE-annotated isoforms for each gene and identifies the most
likely gene model given our PRO-seq data (Supplemental Figure 1.9, Supple-
mentary Methods). This step was particularly important for analyses that de-
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Figure 1.1: Characterizing the dynamic transcriptional response to celastrol
using PRO-seq. (A) PRO-seq was applied to K562 cells collected before celas-
trol treatment (untreated / 0 minutes) and at 10, 20, 40, 60, and 160 minutes af-
ter celastrol treatment. Two biological replicates were performed for each time
point. (B) Distribution of log expression ratios (treated vs. untreated) for each
time point (rlog is a regularized log2 estimate obtained from DESeq2). Only
genes classified as differentially expressed (DE) throughout the time course are
represented. Notice that most DE genes (FDR ≤ 0.01) are down-regulated upon
celastrol treatment. (C) A UCSC Genome Browser display showing raw PRO-
seq data for two differentially expressed genes, EGR1 and KDM3B. EGR1 is
rapidly and strongly repressed (immediate decrease of v 80%), whereas KDM3B
is more gradually repressed, losing v 50% of its expression by 160 minutes.
6
pend on an accurate transcription start site for each gene. We identified a total
of 12,242 protein-coding genes from GENCODE as being actively transcribed in
one or more time-points (Methods). Of these genes, 75.4% were active across
all six time points, 11.7% were active in a single time-point, and the remaining
12.9% were active in 2-5 time-points. Thus, our PRO-seq data and computa-
tional analyses indicate that more than half of all protein-coding genes are tran-
scribed either in the basal condition or during the celastrol response in K562
cells.
The genes that are differentially transcribed in response to celastrol were of
particular interest for further analysis. To measure transcriptional activity spe-
cific to each time point, we used counts of PRO-seq reads mapping to the first 16
kb of each gene body, omitting the first 500 bp to avoid the effects of promoter-
proximal pausing. Because RNA polymerase travels at an average rate of 2
kb/min (Singh and Padgett 2009; Danko et al. 2013; Jonkers et al. 2014; Veloso
et al. 2014) and our time points are separated by at least 10 minutes, this strategy
conservatively considers new transcription only, yet maintains sufficient statis-
tical power for downstream analysis (see Methods). By applying DESeq2 (Love
et al. 2014) to these 16-kb read counts, we identified 6,516 (56%) of the active
genes as being differentially expressed (DE) relative to the untreated condition
(FDR ≤ 0.01). Interestingly, v 80% of these DE genes were down-regulated.
Many genes showed rapid and dramatic down-regulation, with decreases in
expression by half or more at 3.5% of DE genes within 10 minutes, at 7.8% of
DE genes within 20 minutes, and at 48.1% of DE genes within 160 minutes (1.1
1B&C). By contrast, many fewer genes showed substantial increases in expres-
sion; for example, only 0.03%, 1.9%, and 7.7% of DE genes had doubled in ex-
pression after 10, 20, and 160 minutes, respectively. Nevertheless, extreme up-
7
and down-regulation were both rare, with < 1% of DE genes showing increases
and < 1% showing decreases in transcription by factors of eight or more. These
observations are reminiscent of findings for the heat shock response, which have
included general decreases in transcription together with up-regulation of se-
lected stress-response elements (Hieda et al. 2004; Mahat et al. 2016b), but the
effect of celastrol is somewhat less dramatic. We conclude that celastrol broadly
inhibits transcription within minutes after administration but also rapidly acti-
vates a set of genes that may be important for continued cellular viability.
1.3.2 Celastrol activates heat shock more strongly and directly
than it activates the unfolded protein response
Celastrol has been reported to activate stress response pathways such as the
heat shock and unfolded protein responses (Westerheide et al. 2004; Trott et
al. 2008; Mu et al. 2008; Fribley et al. 2015). To see whether these effects
were detectable at the transcriptional level immediately after treatment with
celastrol, we examined our PRO-seq data at genes activated by heat shock
factor protein 1 (HSF1) and genes involved in the three branches of the un-
folded protein response (UPR), corresponding to activating transcription factor
6 (ATF6), inositol-requiring enzyme 1 (ERN1), and endoplasmic reticulum ki-
nase (EIF2AK3) (Figure 1.2A). Because the initial stages of the UPR and heat
shock response are non-transcriptional, we looked for downstream activity of
the first group of transcription factors activated in each pathway, using targets
reported in the Reactome pathway database (Fabregat et al. 2016). Most direct
targets of HSF1 were up-regulated within 160 minutes (Figure 1.2B). Genes en-
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Figure 1.2: Induction of cellular stress responses by celastrol. (A) Illustration
showing key aspects of the unfolded protein response (UPR) and heat shock re-
sponse (HSR), both of which have been reported to be induced by celastrol (Mu
et al. 2008; Trott et al. 2008). Expected transcriptional targets are shown inside
the nucleus, with targets of HSF1, the key transcription factor (TF) activated in
the HSR, in red, and targets of the TFs associated with the three major branches
of the UPR-XBP1, ATF4, and ATF6-in green, purple, and blue, respectively. As-
terisks indicate genes that were differentially expressed in our experiments with
FDR ≤ 0.01. (B) PRO-seq-based log fold changes in expression in K562 cells after
160 minutes of treatment by celastrol for numerous known targets of the same
four TFs: XBP1, ATF4, ATF6, and HSF1. Genes labeled are the same as those
listed in (A). Only targets of HSF1 display strong up-regulation.
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coding chaperone protein HSPH1 and proteinase inhibitor CBP1 were among
the HSF1 targets showing the strongest initial response, with the gene encoding
HSPH1 almost quadrupling its expression in 10 minutes and that for SERPINH1
increasing more than eight-fold in 160 minutes. Most direct targets of the main
UPR TFs (ATF4, ATF6, and XBP1), however, were not strongly induced during
our time course. There were some exceptions to this general rule, such as genes
encoding transcription factor ATF3, chaperone HSPA5, and apoptosis inhibitor
DNAJB9, which more than doubled in expression. It is possible that these tar-
gets are activated earlier than other targets, perhaps by other TFs. In any case,
our observations suggest that celastrol induces a pronounced, rapid transcrip-
tional response in the heat shock pathway, and has a much less pronounced
transcriptional effect on the UPR, although some targets of the UPR are acti-
vated.
Celastrol produces distinct temporal patterns of transcriptional response
Our PRO-seq data for closely spaced time points enabled us to examine the
temporal patterns of transcriptional response to celastrol treatment across the
genome. To group our v6,500 DE genes by shared transcriptional trajectories
across the five time points following celastrol treatment, we used the autore-
gressive clustering algorithm, EMMIX-WIRE, which considers both expression
values at each time point and the correlation of these values over time (Wang
et al., 2012). EMMIX-WIRE identified four clusters of DE genes showing dis-
tinct patterns of transcription (see Methods; Figure 1.3A). Only one of these
clusters (cluster #1) displayed dramatic and sustained up-regulation. In con-
trast, cluster #2 showed rapid and pronounced down-regulation, cluster #3
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Figure 1.3: Clusters of genes showing distinct temporal patterns of response
to celastrol. (A) Differentially expressed genes (FDR ≤ 0.01) clustered by time
series of log2 fold change (LFC) in expression relative to the untreated condition
(0 minutes). Each gene is represented by a blue line, and the red lines indicate
the mean expression per time-point per cluster. Below each cluster is a sum-
mary of the enriched terms in the Reactome ontology (Fabregat et al. 2016)
(FDR ≤ 0.01; see Supplementary Material for details). (B) ChIP-seq data from
Vihervaara et al. (2013) describing binding of HSF1 in K562 cells under normal
(left) and heat-shock (right) conditions, stratified by our cluster assignments.
Each line represents an average over all genes in the cluster in the region of the
TSS, with lighter-colored bands representing 95% confidence intervals obtained
by bootstrap sampling. Notice that cluster one is unique in showing a strong
enrichment for heat-shock-induced binding of HSF1.
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showed delayed down-regulation, and cluster #4 displayed moderate, contin-
uous down-regulation. Interestingly, the expression patterns for these clusters
suggested that the transcriptional response to celastrol occurs largely in two dis-
tinct waves: one within the first ten minutes, and a second between 40 and 60
minutes after treatment. It is possible, however, that additional waves occur but
are undetectable at the resolution of our time points. These findings were robust
to the number of clusters selected, with similar overall behavior for five-, six-,
and seven-cluster models (Supplemental Figures 1.11-1.13).
Each of these clusters was enriched for genes with a distinct biological func-
tion, according to Reactome, a carefully curated database of gene-pathway re-
lationships (Figure 1.3A). To identify these enrichments, we labeled genes with
their associated pathways from Reactome, then used permutation testing to find
pathways overrepresented in each of the four clusters relative to the other three.
Cluster #1 is enriched for genes responsible for the HSF1 response, including
the HSPA family (Supplemental Figure 7). Consistent with this observation,
genes in this cluster have been shown, by ChIP-seq, to bind by HSF1 under heat
shock conditions in K562 cells (Figure 1.3B) (Vihervaara et al., 2013). Cluster
#2 is enriched for a wide variety of terms corresponding to ribosomal assem-
bly, translational initiation, and peptide elongation. The pronounced transcrip-
tional repression of this cluster, together with activity of HSPB1 (HSP27) and
HSPA2 (HSP70), is consistent with reports that celastrol activates the heat shock
response and thereby inhibits translation via HSPB1 in the absence of HSP70
(Cuesta et al. 2000) (Supplemental Figure 1.15,1.16). Cluster #3 is enriched
for pathways that enable DNA replication (e.g., MCM family) and cell cycle
progression (e.g., CDK family; Supplemental Figure 1.17). The delayed down-
regulation of these genes may occur as the cell is preparing to enter replicative
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arrest and, potentially, senescence, consistent with observations that celastrol in-
duces cell cycle arrest and potentiates apoptosis (Feng et al., 2013; Fribley et al.,
2015; Kannaiyan et al., 2011). This transcriptional pattern is also consistent with
our observation that celastrol-treated cells failed to replicate and mostly died
within three days (Supplemental Figure 1.18). Finally, cluster #4 contains es-
sential elements of the RNA splicing machinery (e.g., CD2BP2, CLP1, and the
SRSF kinase family) (Supplemental Figure 1.18). Down-regulation of this clus-
ter is consistent with previous reports that splicing is inhibited under heat shock
(Shalgi et al., 2013). Similar patterns of enrichment were observed with five-,
six-, and seven-cluster models. Overall, these results demonstrate that the com-
ponents of a complex, multi-layered transcriptional response can be disentan-
gled, to a degree, by identifying groups of genes that display distinct temporal
patterns of gene expression.
Several key transcription factors are associated with the celastrol response
Can the distinct transcriptional responses in these clusters of genes be traced to
particular transcription factors (TFs)? To address this question, we used linear
regression to explain the estimated transcription levels at each time point based
on the TFs that apparently bind in the promoter region of each gene (Figure
1.4A). We used two orthogonal sources of information about TF binding: (1)
ChIP-seq peaks for untreated K562 cells (Dunham et al., 2012); and (2) scores
from DeepBind, a machine-learning method that is trained on a combination of
ChIP-seq and in-vitro data and predicts TF-specific binding affinity based on the
DNA sequence alone (Alipanahi et al., 2015). In both cases, we considered the
interval between 500bp upstream and 200bp downstream of the transcription
13
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Figure 1.4: The celastrol response appears to be influenced by various tran-
scription factors (TFs).(A) A schematic representation of the regression model
used to estimate the impact of TF binding. The predicted expression level for
each gene is a linear function of a gene-specific term, a time-point specific term,
and a sum of per-time TF-specific effects weighted by the estimated relative TF
binding affinity in the promoter regions of differentially expressed genes (from
DeepBind or ChIP-seq). Note that the TF binding affinity is estimated from the
untreated state and is invariant across time. (B) The estimated TF- and time-
specific coefficients from the DeepBind-based regression mode. Error bars cor-
respond to the 95% CI estimates for each coefficient. Each gene (e.g., HSF1) is
labeled by its DeepBind motif (e.g., D00470.005) in the legend. Only TFs with
at least one significant time point (FDR ≤ 0.01) and an absolute effect size in the
90th percentile or above are shown. A positive weight for a TF at a given time-
point indicates that genes at which that TF is predicted to be bound showed
increased expression relative to those without it. Negative weights indicate de-
creased expression. The three separate plots represent manually selected clus-
ters of TFs associated with distinct temporal patterns. The time-point-specific
TF coefficients explain v 11% of the residual variance not explained by gene-
specific or time-point-specific terms.
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start site of each active gene. Our regression model included a coefficient for
each TF at each time point. A positive estimate of this coefficient indicated that
increased affinity for a TF was associated with increased expression at a given
time point, whereas a negative estimate indicated that increased affinity for a
TF was associated with decreased expression at that time point.
Between the two TF binding datasets, we identified over twenty TFs as being
significantly associated with changes in gene expression and having a large ef-
fect size (Figure 1.4B, Supplemental Figure 1.20). Of these TFs, E2F4 stood out as
showing a particularly pronounced impact on expression in both datasets. E2F4
is associated with incrementally increased expression between 0 and 60 min-
utes, and with decreased expression thereafter, similar to the expression pattern
of genes in cluster #3, which are associated with cell cycle control. This obser-
vation is consistent with reports that E2F4 is an activator in some contexts but
primarily acts as a repressor responsible for maintaining G2 arrest (Lee et al.,
2011; Polager and Ginsberg, 2003). In addition, we found that the dimerizing
TFs MYC (from ChIP-seq data) and MAX (from DeepBind predictions), were
both associated with an immediate increase in gene expression, followed by de-
creased expression within 20 minutes (Figure 1.4B). This delayed decrease in
expression of MYC- and MAX-bound genes could result from the known dis-
ruption of MYC-MAX dimerization by celastrol (Westerheide et al., 2004; Wang
et al., 2015a). Finally, genes predicted to be bound by SRF also displayed el-
evated gene expression after 40 minutes. SRF has been previously associated
with early and transient induction of cytoskeletal genes in response to heat
stress in murine embryonic fibroblasts (Mahat et al., 2016).
We also found that the paralogous TFs RFX1 (from ChIP-seq) and RFX5
15
(from DeepBind) were both associated with increases in expression. Both of
these TFs have been implicated in regulating the expression of immunity-
related human leukocyte antigen (HLA) genes and both have context-specific
transcriptional repression and activation mechanisms (Katan et al., 1997; Vil-
lard et al., 2000; Xu et al., 2006), so it is possible that they contribute to celastrol’s
anti-inflammatory effects. However, RFX1 was not tested with DeepBind and
its motif is quite similar to that of RFX5, so it is impossible to know from our
data whether one or both of these TFs are important in the celastrol response
(notably, they do have different binding patterns in vivo in the untreated condi-
tion; Supplemental Figure 1.20B,C). Nevertheless, our regression framework is
useful in providing a list of candidate TFs whose binding preferences correlate
with aspects of the celastrol response.
1.3.3 Increased polymerase pausing is broadly associated with
transcriptional repression
Promoter-proximal pausing of RNA polymerase is a rate-limiting and indepen-
dently regulated step in productive transcription (Andrulis et al., 2000; Wu et al.,
2003). Notably, the peaks of paused RNA polymerase at DE genes doubled in
height during our time course (Figure 1.5A, Supplemental Figure 1.21). Accord-
ingly, we found that the “log pause index,” or log2 ratio of average read depth
at the pause peak to that in the proximal gene body, increased by more than 1
(corresponding to a fold-change of more than 2 in the pause index) in DE genes
by 160 minutes (Figure 1.5B). Together, these observations indicate that most
DE genes undergo increased pausing after celastrol treatment, suggesting that
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Figure 1.5: Increased promoter-proximal pausing is associated with transcrip-
tional repression in the response to celastrol. (A) Mean PRO-seq signal at pro-
moters for all active genes, grouped by time point and oriented with respect to
the direction of transcription of the gene. X-axis represents distance to the cen-
ter of the divergent transcription start site (see Methods). Intervals around each
line represent 95% confidence intervals obtained by bootstrap sampling. Notice
the general increase in the height of the pause peaks with time. (B) The distri-
bution of changes in the log fold index with respect to the untreated condition
(∆LPI; see Methods) for all active genes at each time point. The notch corre-
sponds to median +/− 1.58 · IQR/√n, roughly a 95% confidence interval of the
median. (C) The distribution of ∆LPI for all DE genes (FDR ≤ 0.01) by cluster
and time-point. Notice that all clusters show an increase in the pause index with
time, except for cluster #1. Error bars indicate the 25th and 75th percentiles of
the data.
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pause release may be widely inhibited during the celastrol response.
To see if particular expression patterns were associated with changes in
pausing, we separately examined the changes in log pause index during the
time course for each of our six gene expression clusters. Interestingly, we found
that pausing increased in all clusters with the exception of cluster #1 (Figure
1.5C), the only strongly up-regulated cluster (see Figure 1.3A), where pausing
decreased for the majority of genes, but increased or remained unchanged for
a significant fraction of them (Supplemental Figure 1.21B). Thus, changes in the
log pause index are generally negatively correlated with changes in expression
across clusters. This observation suggests that decreases in the rate of release
of paused Pol II to productive elongation could contribute to increased pausing
and, hence, to down-regulation of transcription, while the absence of such an
effect (in cluster #1) might permit up-regulation of transcription (Mahat et al.,
2016; Zeitlinger et al., 2007). As cluster #1 is strongly associated with the HSF1
response, this finding is consistent with previous reports that HSF1 regulates
transcription by increasing the rate of release of paused RNA polymerase into
productive elongation (Mahat et al., 2016). Nevertheless, it is also possible that
the inverse correlation between pausing and expression is a consequence of
“mass action” of available Pol II (see Discussion).
1.3.4 Heat shock induces a similar, but more pronounced, tran-
scriptional response than celastrol
Celastrol is known to mimic heat-shock in many respects (Westerheide et al.,
2004), but it remains unclear how similar the transcriptional responses to these
18
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Figure 1.6: Celastrol downregulates most of the same genes as heat shock,
but upregulates many different genes. (A) Venn diagram of genes that are
up-regulated after 30 minutes of heat shock vs. after 40 minutes of celastrol
treatment. (B) Venn diagram of genes that are down-regulated after 30 minutes
of heat shock vs. after 40 minutes of celastrol treatment.
two stimuli are. To address this question more directly, we obtained PRO-seq
data for heat-shock treated K562 cells from a recently published study (Viher-
vaara et al., 2017) and processed it identically to our celastrol data. We focused
on comparing the heat-shock data for 0 and 30 minutes (the only time points
available) with our celastrol data for 0 and 40 minutes, additionally consider-
ing our 60- and 160-minute time-points for some analyses (Supplemental Fig-
ure 1.22A&B). In general, heat shock induced a broader response than celastrol
treatment, with twice as many genes differentially expressed after 30 minutes
of heat shock (4,604) vs. after 40 minutes of celastrol treatment (2,302). Of the
1,301 genes that were up-regulated in response to either treatment, 21% were
shared between the heat shock and celastrol responses, and of the 4,230 that
were down-regulated in response to either treatment, 25% were shared (Figure
1.6). As with celastrol treatment, the pause index significantly increased after 30
minutes of heat shock. Taken together, these results suggest that there are many
commonalities between the early transcriptional responses to the heat shock
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and celastrol treatments, but also many differences.
We then sought to characterize the pathways underlying major differences
between the celastrol and heat shock responses. Using Reactome, we tested
for functional enrichments among shared and non-shared DE genes, sepa-
rately considering up- and down-regulated genes. We found that genes down-
regulated only in the celastrol response were enriched for mitochondrial en-
ergy production and translation of mitochondrial genes (Supplemental Figure
1.23A). By contrast, down-regulated genes specific to the heat-shock response
were enriched for MAP kinase signaling and cell-cycle progression (Supple-
mental Figure 1.23B), whereas down-regulated genes that were shared in both
responses were strongly enriched for ribosomal formation and translation (Sup-
plemental Figure 1.23C). For the up-regulated genes, the heat-shock-only genes
were enriched for GPCR signaling, and the shared genes were dominated by
heat-shock response pathways in agreement with the analyses discussed above
(Supplemental Figure 1.24A&B); no pathways were significantly enriched in the
celastrol-only response.
Finally, we searched for pathways whose genes tended to change expres-
sion in opposite directions in the heat shock and celastrol responses. We com-
pared the 40, 60, and 160-minute time-points for celastrol to the 30-minute heat-
shock time-point. One pathway, cholesterol biosynthesis, emerged from this
analysis as down-regulated in celastrol at both 60 and 160 minutes but up-
regulated in heat-shock (Supplemental Figure 1.25A). This observation is con-
sistent with previous findings for mammalian cells that heat shock increases ac-
tivity of the MVA pathway, a key cholesterol biosynthesis pathway (Shack et al.,
1999). The central regulatory enzyme in the MVA pathway, HMGCR, is clearly
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up-regulated in heat shock and down-regulated at 60 minutes in celastrol. We
investigated whether sterol response element binding factor 1 (SREBF1), an im-
portant TF for cholesterol biosynthesis genes (Brown and Goldstein, 1997), was
a potential mechanism for decreased genic expression in the celastrol response
by asking if genes bound by SREBF1 in untreated cells showed decreased ex-
pression relative to those not bound across the celastrol time-course (Supple-
mental Figure 1.25B). We found that genes that were strongly bound by SREBF1
in untreated cells, in comparison to unbound genes, went from being more
highly expressed in the untreated condition, to having similar mean expres-
sion at 60 minutes of treatment, and lower mean expression at 160 minutes of
treatment. These results demonstrate that despite having many similar effects,
celastrol and heat shock have opposite effects on the expression of genes in-
volved in cholesterol biosynthesis.
1.3.5 Enhancers show similar functional associations and paus-
ing patterns to genes
Previous studies have shown that putative enhancers are divergently tran-
scribed, producing nascent RNAs that can be detected via PRO-seq (Danko
et al., 2015; Core et al., 2014; De Santa et al., 2010). Using dREG (Danko et al.,
2015), which predicts divergent transcription start sites (dTSS) from stranded
GRO/PRO-seq data, we identified 25,891 apparent dTSS from our PRO-seq
data, pooling calls across time points. Based on the distance from nearest an-
notated genic TSS, we classified 7,334 of these dTSS as likely transcribed en-
hancers, 15,941 as likely promoters, and the remaining 2,616 as ambiguous. For
21
Figure 1.7: Response to celastrol at predicted transcribed enhancers. (A) Di-
vergent transcription start sites (dTSS) that were classified by distance-based
rules as likely enhancers or promoters show distinct patterns of histone marks
in untreated K562 cells. Shown are H4K4me1 (enriched at enhancers), H3K4me3
(enriched at promoters), and H3K27ac (enriched at both). PRO-seq read counts
are shown for comparison. X-axis is oriented by direction of transcription of
nearest gene. (B) Gene Ontology (GO) biological processes associated with dif-
ferentially expressed enhancers using GREAT (McLean et al. 2010). Bar plot
represents –log10 p-values for enrichment, with numerical fold enrichments in-
dicated at right. (C) Metaplot of PRO-seq signal at all enhancers, centered on
the dTSS, per time-point. Units of PRO-seq signal are average numbers of reads
per 10bp bin. Intervals around each line represent a 95% confidence interval ob-
tained by bootstrap sampling. (D) The distribution of DeepBind scores for HSF2
and JUND for transcriptionally activated and unchanged sets of enhancers. The
notch corresponds to the median +/− 1.58 · IQR/√n, roughly a 95% confidence
interval of the median.
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validation, we examined ChIP-seq data from ENCODE for untreated K562 cells,
and found, as expected, that enhancer and promoter classes were both strongly
enriched for acetylation of histone H3 at lysine 27 (H3K27ac), and that the pro-
moter class was more strongly enriched for RNA polymerase and trimethy-
lation of histone H3 at lysine 4 (H3K4me3) (Figure 1.7A). The enhancer class
also showed moderate enrichment for monomethylation of histone H3 at ly-
sine 4 (H3K4me1). These observations confirm that PRO-seq serves as an effi-
cient single-assay approach for characterizing both transcribed enhancers and
protein-coding genes in our system (Danko et al., 2015).
To better understand the role of the non-coding regulatory elements in the
celastrol response, we further examined 1,479 ( 20%) of the 7,334 dTSS-based en-
hancers that were classified as differentially transcribed. We attempted to find
functional enrichments for potential target genes of these differentially tran-
scribed enhancers using the Genome Regions Enrichment of Annotations Tool
(GREAT, Ver. 3.0; see Methods), which associates candidate regulatory elements
with likely target genes according to distance-based rules and then tests those
genes for functional enrichments (McLean et al., 2010). GREAT identified en-
richments for processes relating to apoptosis, translational regulation, and re-
sponses to various environmental stresses (Figure 1.7B), in general agreement
with our analysis of DE genes. We also found that our set of putative enhancers
displayed an accumulation of paused polymerase after celastrol treatment (Fig-
ure 1.7C, Supplemental Figure 1.26). Although the functional significance of
pausing at enhancers is unknown, this observation suggests that global shifts in
pause levels at genic TSS are also reflected at enhancers.
Finally, we sought to determine which TFs influenced activity at enhancers.
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Because sparse data at enhancers resulted in noisier estimates of transcription-
ally engaged RNA polymerase than at genes, we focused in this case on a rel-
atively small group of 480 enhancers that showed little activity at 0 minutes
but greatly increased activity by 160 minutes (see Methods). We compared
DeepBind scores for these activated enhancers with those for non-DE enhancers
that had similar absolute expression levels and found six TFs whose motifs had
significantly elevated scores for sequence elements in the activated enhancers:
HSF1/2, JUND, FOSL2, MAFK, STAT3, and THRA (Supplemental Figure 1.27;
1.7D). Of these TFs, HSF2, was also associated with increased expression in
genes, while JUND and FOSL2 are subunits of AP-1, a TF previously found
to regulate cellular growth and senescence (Shaulian and Karin, 2001). Because
these TFs were identified simply based on their sequence preferences, TFs with
similar motifs are also potential regulators. For example, it is possible that JUN,
whose expression increases over the time course and which is known to be ac-
tivated by HSF1 (Sawai et al., 2013), is actually responsible for the apparent
association with JUND, which does not appear to be activated. We also cannot
effectively distinguish between HSF1 and HSF2 binding here. In addition, since
this analysis was limited to TFs that increased transcription at enhancers, it is
unsurprising that it did not identify TFs associated with decreased expression
in the genic response, such as MAX. Despite these caveats, these results demon-
strate that PRO-seq can be used to detect transiently activated enhancers and
identify candidate TFs that may drive the enhancer response.
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1.4 Discussion
This study represents the first genome-wide assessment of the immediate tran-
scriptional effects of celastrol, including transcribed regulatory elements as well
as genes, shedding light on some of the possible primary targets and mech-
anisms of action of this potent therapeutic compound. We find that celastrol
treatment results in pervasive transcriptional down-regulation, with nearly half
of expressed genes being down-regulated within 160 minutes. A much smaller
group of genes, roughly 10% of those expressed, are up-regulated during the
same time interval. By analyzing the sequences nearby transcription units, we
were able to identify several transcription factors whose binding patterns par-
tially explain these transcriptional responses. We also observed a clear impact
from celastrol on polymerase pausing at both genes and enhancers, which is
negatively correlated with changes in transcriptional activity. While there are
limits to what can be learned from PRO-seq data alone, we have shown that
when these data are collected at relatively high temporal resolution and ana-
lyzed together with other data for the untreated condition, they can provide
valuable insights into a multifaceted, multistage cellular response to a transcrip-
tional stimulus.
We find that celastrol treatment generally induces a similar response to
heat shock, consistent with previous reports (Trott et al., 2008; Westerheide
et al., 2004). Heat-shock has also been observed to induce widespread down-
regulation in mammalian cells (Hieda et al., 2004; Mahat et al., 2016; Vihervaara
et al., 2017). Moreover, many of the same genes that are up-regulated upon
celastrol treatment are also bound by HSF1 after heat shock or participate in
heat-shock pathways. In addition, sequences associated with HSF1 binding are
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associated with increased gene expression, according to our regression anal-
ysis. Finally, our direct comparison showed that both treatments lead to up-
regulation of genes involved in the heat shock response, and down-regulation
of genes involved in ribosomal formation and translation.
Together, these findings suggest that HSF1 is activated soon after celastrol
treatment, whereupon it activates a large group of genes. These observations
suggest that, in part, the transcriptional response to celastrol may simply be a
general cellular stress response. Cellular stress responses are known to affect
a broad range of cellular functions, including cell cycle arrest, transcription of
molecular chaperones, activation of DNA damage repair pathways. removal of
irretrievably damaged macromolecules, and apoptosis upon severe damage (de
Nadal et al., 2011), and they are relevant in many diseases, including cancer (Bi
et al., 2005), proteotoxic diseases (Mu et al., 2008), and autoimmune disorders
(Todd et al., 2008). Previous studies have investigated cellular stress responses
at the delayed transcriptional (Mahat et al., 2016; Teves and Henikoff, 2011),
post-transcriptional (Gardner, 2008), translational (Shalgi et al., 2013), and post-
translational levels (Golebiowski et al., 2009; Urano et al., 2000). Together with
similar studies of heat shock (Mahat et al., 2016), our study helps to illuminate
specific features of the early transcriptional response to stress.
Nevertheless, we observed several differences between the heat shock and
celastrol responses. The most striking difference was that genes associated with
the cholesterol synthesis pathway are activated by heat shock but repressed by
celastrol. This observation is consistent with reports that celastrol decreases en-
dogenous cholesterol in mice and reduces obesity (Ma et al., 2015; Liu et al.,
2015; Zhang et al., 2016). Further analysis suggested that loss of SREBF1 bind-
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ing may be responsible for the difference in the celastrol response. Given that
SREBFs are activated via proteolytic cleavage from an intermembrane protein
when sterols are scarce (Wang et al., 1994), it is possible that celastrol inhibits
cholesterol synthesis by inhibiting SREBF1 cleavage and release. Alternatively,
or in addition, celastrol could inhibit cholesterol synthesis by decreasing the
stability of the SCAP-SREBF complex (Kuan et al., 2017; Zhang et al., 2009).
Another apparent difference between the heat-shock and celastrol responses
has to do with the kinetics at genes that appear to be regulated by SRF, a tran-
scription factor associated with HSF1/2-independent up-regulation after heat-
shock. We observed an enrichment for SRF binding sites in the core promoters
of genes that displayed elevated expression after 40 minutes of celastrol treat-
ment. By contrast, previous findings for heat shock (Mahat et al., 2016) have
indicated that SRF-mediated up-regulation occurs much more rapidly, as early
as 2.5 minutes after treatment. Finally, our analysis suggests that the loss of
binding by MYC-MAX may be responsible, in part, for the broad transcrip-
tional repression we observe within 20 minutes of celastrol treatment. To our
knowledge, MYC-MAX inhibition has not been reported to be important in the
heat-shock response. The finding for celastrol is supported by previous studies
showing that celastrol directly inhibits MYC-MAX functionality (Wang et al.,
2015b). Since MYC-MAX is a strong transcriptional activator and is bound at
over 6,000 promoters of active genes in K562, its inhibition may be an impor-
tant contributing factor to widespread down-regulation after celastrol treatment
(Amati et al., 1992, 1993).
A major strength of our experimental approach is that it allows us to observe
transient as well as sustained transcriptional responses. For example, we found
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that E2F4, a transcriptional repressor, was quickly down-regulated after celas-
trol treatment, reducing in expression by half within 20 minutes. Despite loss
of this repressor, target genes of E2F4 were increasingly down-regulated (rather
than up-regulated, as expected) after 60 minutes (Lee et al., 2011). These ob-
servations suggest that the apparent increased repression activity of E2F4 dur-
ing the celastrol response may have a non-transcriptional basis. Interestingly,
previous studies have shown that celastrol inhibits CDK4, and that CDK4 over-
expression disrupts E2F4 DNA-binding ability (Peng et al., 2010; Scime` et al.,
2008). Thus, it is possible that celastrol increases the DNA binding of E2F4 to
DNA, which in turn could contribute to cell-cycle arrest (Lee et al., 2011; Polager
and Ginsberg, 2003).
Another advantage of our densely sampled PRO-seq time course is that it
allows us to measure changes in promoter-proximal RNA polymerase pausing.
We observed that pause indices increased by more than two-fold at differen-
tially expressed genes during our time course. We also found that increase
pausing was associated with decreased transcription in genes, as previously
reported for heat-shock conditions (Mahat et al., 2016), although we did not ob-
serve a converse association between decreased pausing and up-regulation of
genes. A possible mechanism that could contribute to this increased pausing
in down-regulated genes is the celastrol-induced disruption of the MYC-MAX
complex, which has been shown to recruit P-TEFb, which in turn broadly facil-
itates pause release (Kanazawa et al., 2003). This mechanism could in principle
affect down-regulated genes only, for example, if up-regulated genes recruit P-
TEFb independently of MYC-MAX (e.g., through the activity of HSF1; Lis et al.
(2000)).
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While it is possible that increased pausing causes decreased expression, by
limiting productive elongation and therefore reducing transcription levels, an
alternative possibility is that increased pausing is a consequence of “mass ac-
tion”—that is, decreased transcriptional activity across many genes results in
increased availability of free Pol II, some of which ends up being loaded on pro-
moters and coming to rest at pause sites (Mahat et al., 2016). In other words,
the negative correlation between pausing and expression could be explained
by causality in either direction, or perhaps in both directions. Additional ex-
periments will be needed to establish the causal basis of these correlations. In
any case, our observations suggest that changes in pausing are widespread and
broadly associated with transcriptional repression, and therefore may play an
important role in the celastrol response.
1.5 Materials and Methods
1.5.1 Celastrol treatment
K562 cells were cultured at 37◦C in RPMI media (Gibco) containing 10% FBS
(Gibco), Pen Strep (Gibco) and 2 mM L-Glutamine (Gibco). Biological replicate
cell cultures were prepared as follows: after thawing K562 cells and seeding
a fresh culture, cells were split into two separate flasks, which would remain
separated through six passages and expansions until treatment and collection
for preparation of PRO-seq libraries. Cells from each expanded replicate were
seeded onto six 30-mL dishes (one for each time point) at a density of 5x105
cells/mL and then incubated for an additional doubling cycle (v20 hrs). For
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treatments, fresh celastrol was dissolved in DMSO at a final concentration of
20 mM. Celastrol-treated samples received celastrol (Sigma) at a final concen-
tration of 3 µM, whereas untreated (0-minute) samples received an equivalent
volume of DMSO. Cells remained in culture dishes in the incubator during the
time course. Time-course treatments were carried out in reverse order so that
all samples would be collected at the same time (starting with 160-minute time
point and ending with the untreated).
1.5.2 Cell permeablization and PRO-seq
Samples were then prepared for precision run-on reactions by subjecting cells to
permeablizing conditions. Briefly, cultures were spun down and resuspended
in ice cold 1xPBS. Samples were spun again and washed in 5 mL wash buffer (10
mM Tris-Cl, pH 7.5; 10 mM KCl; 150 mM sucrose; 5 mM MgCl2; 0.5 mM CaCl2;
0.5 mM DTT; 1x Protease inhibitor cocktail (Roche); 20 units RNase inhibitor
(SUPERase In, Invitrogen)). Cell pellets were then resuspended in permeabliza-
tion buffer (10 mM Tris-Cl, pH 7.5; 10 mM KCl; 250 mM sucrose; 5 mM MgCl2;
1 EGTA; 0.05% Tween-20; 0.1% NP40; 0.5 mM DTT; 1x Protease inhibitor cock-
tail (Roche); 20 units RNase inhibitor (SUPERase In, Invitrogen)) and left on ice
for 5 minutes. Cells were checked for penetration by trypan blue to assess per-
meability (v99% permeable). Cells were then washed two times in 5 mL wash
buffer before being resuspended in 200 µL storage buffer (50mM Tris-Cl, pH
8.3; 40% glycerol; 5 mM MgCl2; 0.1 mM EDTA; 0.5 mM DTT). A one-to-fifty
dilution was prepared using 2 µL of each sample and used to take OD600 mea-
surements. All samples were then diluted to an equal density (OD600 = 0.181)
in a final volume of 110 µL of storage buffer. 5x104 pre-permeabilized S2 cells
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were then spiked in to each cell count-normalized sample before flash-freezing
the permeablized cells and storing them at -80◦C. Stored permeable cells with
spike-ins were thawed on ice and each sample was subjected to the precision
run-on protocol (Mahat et al. 2016a). Run-on reactions incorporated only bi-
otinylated NTPs with no un-modified NTPs. All libraries were subjected to nine
cycles of PCR amplification before size selection and gel purification.
1.5.3 Cell counting
Cells were either treated with 3µM celastrol, DMSO, or left untreated for four
days. Live/dead cells were determined based on trypan blue staining. Counts
were measured with an automatic cell counter (Bio-rad).
1.5.4 Read mapping
All filtered reads were removed from each fastq file, then cutadapt (v1.9.1) was
run with the following options:
cutadapt -a TGGAATTCTCGGGTGCCAAGG -m 15
to remove the Illumina adapters and discard all remaining reads that were less
than 15bp in length. All reads were then trimmed to 34bp in length using
fastx timmer (v0.0.13.2) to avoid biasing read mapping away from gene pro-
moters. The trimmed reads were then aligned to the joint hg19/bdgp6 genome
using the STAR aligner (v2.4.0i) (Dobin et al., 2013). Reads aligning to hg19 and
bdgp6 were then separated and bigwigs were created by converting each read
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to a single count at its 5’ end. While human assembly hg19 was used for read
mapping, we do not expect the use of the more recent hg38/GRCh38 would
have an appreciable impact on our results, as the major differences between
these assemblies concern alternative haplotypes and centromeric regions.
1.5.5 Detection and resolution of dTSS
dREG was run on each sample as described previously (Danko et al., 2015), pro-
ducing a set of genomic intervals corresponding to predicted divergent tran-
scription starts sites (dTSS). These initial dREG calls had fairly coarse resolu-
tion, ranging in size from several hundred to thousands of bases. We therefore
applied a heuristic scanning method to identify one or more higher-resolution
dTSSs within each dREG call. Briefly, this method involved sliding a window
along a dREG interval and considering the relative read counts among three
subintervals: a peak, a flank, and center. To identify pairs of divergent peaks,
the test was applied simultaneously to each strand in a strand-specific manner,
and the results were combined. Specifically, for a scan initiated at base i, the
center was defined as the interval [i, i + 110), the shoulder as [i − 50, i), and the
flank as [i − 250, i − 150). Three one-sided binomial tests were performed, test-
ing that there are fewer reads in the center than the flank, the center than the
shoulder, and the flank than the shoulder. The sum of the resulting six negative
log p-values (three for each strand) then became the per-base score. The best
scoring window in a dREG region was taken as a dTSS. In addition, up to two
other dTSSs were called if their score exceeded 20.
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1.5.6 Classifications of dTSS
dTSS were classified as either enhancers or promoters based on their relative
distance from the set of all TSSs annotated in GENCODE v19. To classify each
dTSS, the following rules were applied: (1) if the dTSS was greater than 1 kb,
and at most 1 Mb, away from the nearest annotated promoter, it was classified
as an enhancer; (2) if the dTSS was within 200 bp of an annotated promoter, or
it was within 1 kb of an annotated promoter and it was the closest dTSS to the
promoter, it was classified as a promoter; (3) if the dTSS was between 600bp and
1 kb away from the nearest annotated promoter, and not the closest dTSS to the
promoter, It was classified as an enhancer; (4) otherwise, the dTSS was classified
as unknown.
1.5.7 Selection of active transcripts in K562 cells
Selection of transcripts was performed by a new program, called TuSelector.
First, a list of potential transcripts was obtained from GENCODE v19. The genic
regions and data were partitioned into 100bp intervals. For each gene, a set
of coarse-grained overlapping transcript models was created, where for each
transcript model and interval, the interval was assigned to the transcript model
if, and only if, it overlapped the corresponding annotated transcribed region
by more than 50% at the nucleotide level. Next, the PRO-seq read counts in
each 100 bp interval were summarized by a 1 if there were reads aligned to
the interval or a 0 otherwise. TuSelector computed a likelihood for each of the
possible coarse-grained transcript models at a given gene, as follows:
L(T ) =
∫
θt
P(θt)
∏
i
P(X = xi|θt)δ(i,T )
 dθt · ∫
θu
P(θu)
∏
i
P(X = xi|θu)1−δ(i,T )
 dθu
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where T is the transcript model, the products range across genomic intervals i,
xi is the summary of the data in interval i (0 or 1), δ(i,T ) is an indicator func-
tion that takes value 1 when interval i is included in T and 0 otherwise, X is
a Bernoulli random variable, and θt and θu are the parameters for this random
variable in the transcribed and untranscribed states, respectively. P(θt) is as-
sumed to be uniform over the interval (0.3, 1), and P(θu) is assumed to be uni-
form over the interval (0.01, 0.03). In practice, we discretized θu into segments of
size 0.01 and θt into segments of size 0.05, and approximated the integrals with
finite sums. Finally, in addition to the annotated transcripts, we considered a
competing model representing a completely untranscribed gene.
TuSelector was run separately for each replicate and time point, and poten-
tially produced discordant transcript calls across these runs. Therefore, we se-
lected at most one “consensus” transcript model per gene for use in further anal-
ysis, as follows. To be considered a consensus call, TuSelector had to identify
the same transcript model at least 80% of the time with at least 50% of replicate
pairs both having the same transcript call. Two transcript models were consid-
ered “the same”if their endpoints differed by less than 500bp. If no transcript
model met these criteria, the gene was not considered in further analysis.
1.5.8 Estimating expression and detecting differentially ex-
pressed genes
For all active, protein-coding transcripts, reads were taken from up to the first
16 kb of the gene, minus the first 500bp to avoid an influence from promoter-
proximal pausing. This strategy allowed us to focus on the most recent tran-
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scription at each time point and avoid averaging over time. The maximum in-
terval of 16 kb was based on a minimum interval between time points of 10
minutes and an average polymerase transcription rate of v2 kb/min, minus a
few kilobases of “padding”. Any genes that were shorter than 700 bp were re-
moved from the analysis. A size factor for each sample was obtained by taking
the number of spike in reads per sample divided by the median number of spike
in reads per sample. To estimate expression of transcriptional enhancers, reads
were taken from 310 bases (assuming a 110-base spacing between dTSS as re-
ported by Core et al. plus 100bp to either side) centered on the dTSS. Both sets
of read counts were fed jointly into DESeq2, and enhancers and genes were sub-
sequently separated for further analysis. An enhancer or gene was called as DE
with an FDR ≤ 0.01 using a likelihood ratio test.
1.5.9 Clustering differentially expressed genes
Gene expression log-fold changes were computed relative to the untreated
(zero-minute) time-point using the DESeq-based estimates of absolute expres-
sion (rlog values). All DE genes were then fed into the autoregressive clustering
program EMMIX-WIRE using default settings. Likelihood values for between
two and ten clusters were computed. We selected four clusters as a value at
which the increases in likelihood with the number of clusters began to decline.
To check for the robustness of our selection we repeated our analyses with five
and seven clusters and found that they were not highly sensitive to the cluster
number.
36
1.5.10 Computing functional enrichment for gene clusters
Reactome (v52) was used to assign genes to functional categories. Genes that
were not annotated in Reactome were removed. The background set for all
enrichments was the set of DE genes present in Reactome. Odds ratios were
computed per cluster (c) and pathway (p) as:
OR =
Xc,p/Xc,¬p
X¬c,p/X¬c,¬p
where X represents a count and c and ¬c denote the sets of genes in, and not in,
cluster c, respectively, and, similarly, p and ¬p denote the sets of genes in, and
not in, pathway p. An empirical null distribution of odds ratios was computed
by randomly shuffling the gene assignments to pathways 100,000 times. P-
values were then computed from this distribution and the Benjamini-Hochberg
procedure was applied to estimate false discovery rates (FDRs).
1.5.11 Characterizing genic regulation
ChIP-seq data was downloaded from the ENCODE website (https://www.
encodeproject.org) in narrowPeak format (optimal idr) on Sep. 30th, 2016.
Scores for each gene-TF pair were computed by taking the peaks with the max-
imum signal that intersected [-200,+500] around the promoter. DeepBind v0.11
was run over [-200,+500] around the promoter with standard settings using all
non-deprecated motifs for DNA binding proteins (Alipanahi et al., 2015). Deep-
Bind and ChIP-seq scores were then standardized to control for differences in
range. To analyze TFs that may be involved in different regulatory patterns
we linearly regressed genic expression (as estimated by DESeq2) against scores
from ChIP-seq or DeepBind with time point specific coefficients for each TF and
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a time agnostic, gene-specific coefficient to capture the fixed effect of unmod-
eled regulation (Alipanahi et al., 2015; Neph et al., 2012). In this framework, the
expected expression of a given gene i at time j is expressed as:
Yi, j = βi + β j +
∑
k
βi jkxik
where βi is the gene-specific expression bias term, β j is a time-specific bias term,
and βi jk is the coefficient for the time-point specific effect of a TF k. Standard
deviations for each coefficient were estimated via 1000 bootstraps. Finally, the
list of TFs was filtered to keep those with FDR ≥ 0.01 in at least one time point
and with a maximal change between any two coefficients in the 90th percentile.
This procedure selected for TFs having an effect that was both statistically sig-
nificant and of large magnitude. A set of per TF F-statistics was also calculated
and are available as supplemental tables (Supplemental Table 1.1,1.2).
1.5.12 Identification and analysis of genic pause peaks
To locate pause peaks, we scanned each active transcript (see above) greater
than 1 kb in length in the region of the annotated TSS ([TSS-200,TSS+200]), tak-
ing the number of reads in a 50-bp sliding window, with a sliding increment
of 5 bp. The window with the largest number of reads in the untreated con-
dition (0-minute time point) was designated as the pause peak. To compute
a log2 pause index (LPI), we subtracted the DESeq-estimated log2 read count
(the “rlog” value) for the gene body from the equivalent DESeq-estimated log2
read count at the peak. Furthermore, to compute changes in this value over
time, we subtracted the LPI for the zero time-point from the LPI for each subse-
quent time point; that is, the change in LPI at time t, denoted ∆LPIt, was given
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by ∆LPIt = LPIt–LPI0. Notice that normalizing changes in the pause peak by
changes in the gene body in this way only increases if the number of reads in
the peak increases by more than the number of reads in the gene body.
1.5.13 Analysis of heat shock data
PRO-seq heat shock gene expression values were computed in an identical man-
ner to the celastrol data with the exception of the computation of size factors,
which obtained directly from a previous analysis (Vihervaara et al., 2013) Gene
transcripts were the same as those used for the celastrol data. P-values were
(re-)computed using the Wald test instead of the LRT for both the celastrol and
heat-shock data to allow for a single time-point analysis. Differences in the dis-
tributions of gene expression within a pathway between HS and celastrol re-
sponses were evaluated using the Kolmogorov-Smirnov test.
1.5.14 Estimating expression in enhancers
To prevent contamination from genic transcription, all dTSS previously anno-
tated as enhancers were extended by 1 kb to either side and removed if any
part of the extended enhancer was within 5 kb of a gene body. DESeq was used
to estimate the transcription level in the enhancer peaks, tails, and the whole
enhancer body. The enhancer peak was defined as ±250 bp from the center of
the enhancer, the tail was ±400 to ±1000 bp from the center, and the whole en-
hancer was 0 to ±1000 bp from the center of the enhancer. Read counts were
summed from both strands for each region (i.e., peak = plus strand [0,+250]+
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minus strand[-250,0]), and then DESeq2 was used to estimate fold changes. En-
hancers were called as strongly activated if they were differentially expressed
with FDR ≤ 0.01, rlog(expression at 0 min) ≤ 1, and were in the 90th percentile
for fold change between 0 and 160 minutes. To get the same number of simi-
larly expressed non-differentially expressed enhancers, we performed rejection
sampling on enhancers that were differentially expressed with FDR ¿ 0.5 using
their average expression values between 0 and 160 minutes and probabilities
calculated from a kernelized histogram of the activated enhancer’s expression
at 160 minutes.
1.5.15 Data Access
The sequencing data from this study have been submitted to the NCBI Gene Ex-
pression Omnibus (GEO; http://www.ncbi.nlm.nih.gov/geo/) under
accession number GSE96869.
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1.6 Supplemental Figures
Figure 1.8: Concordance in read-counts between replicates in gene bodies on
the negative strand.
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Figure 1.9: Example of tuSelector call in the presence of multiple GEN-
CODE transcripts. (A) Illustration of the coordinates of each uniquely iden-
tifiable candidate transcript model (obtained from GENCODE annotations) for
C1orf122. All models differ in state (transcribed vs. untranscribed) in at least
one bin. (B) The posterior probability of each transcript model as computed
by tuSelector. (C) The raw PRO-seq data labeled with the state calls (tran-
scribed/untranscribed) for the most likely transcript model. Notice in this case
that there is a weak indication of transcription near the start of the longest tran-
script model, but the absence of transcription in the middle region, and the dif-
ference in read depth compared with the stronger evidence at the right (in red),
suggest that a shorter transcript model is much more likely overall. (D) Some
performance metrics to compute how well the data matches the most likely an-
notated transcript. GOF is the fraction of bins at which an independent predic-
tion of transcription (not considering other bins) agrees with the corresponding
state in the most likely transcript model. LNMG is the longest non-matching
group of consecutive bins whose individual state calls do not agree with the an-
notated state in the most likely model. Each dot matches a 50-bp bin of reads. If
labeled “true,” the independent state calls agree with the state in the most likely
model, and if labeled “false,” they do not agree.
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Figure 1.10: Validation of choice of 16 Kb interval for estimating transcription
levels of genes. Here we compare 16 Kb intervals with alternative intervals
of 8 Kb and 32 Kb, in all cases starting 500bp after the TSS (to avoid pausing
artifacts). For example, the 8Kb label indicates that reads were counted in the
interval [TS S + 500,TS S + 8500). (A) Overlap between gene sets called as dif-
ferentially expressed (DE) using the likelihood ratio test (LRT) at FDR ≤ 0.01
for different interval lengths. (B) Total numbers of genes called as DE using the
likelihood ratio test (FDR ≤ 0.01) for different interval lengths. (C) Numbers of
genes called as DE per interval length at each individual time-point using the
Wald test, since our LRT aggregates across time-points (FDR ≤ 0.01). The results
are similar across interval lengths, but the shorter lengths result in somewhat
decreased numbers of DE genes at later time points due to reduced statistical
power deriving from consideration of fewer sequencing reads. At the same
time, the shorter lengths result in slightly improved sensitivity for differential
expression at 10 minutes. Overall, the 16 Kb length cutoff appears to strike a
good balance between sensitivity for immediate changes of large effect and sen-
sitivity for delayed changes of modest effect.
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Figure 1.11: Clustering of DE genes into five clusters and summary of en-
riched cluster-specific terms.
Figure 1.12: Clustering of DE genes into six clusters and summary of enriched
cluster-specific terms.
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Figure 1.13: Clustering of DE genes into seven clusters and summary of en-
riched cluster-specific terms.
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the other clusters (FDR ≤ 0.05). Annotation similarity indicates what fraction
of genes (based upon the term associated with less genes) are shared between
two terms.
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Figure 1.15: Expression of HSPB1 and HSPA2, key genes in heat-shock in-
duced translational repression. (A) Expression of HSPB1 with each library
normalized by size factor and replicates for each time point added together. (B)
Expression of HSPA1 with each library normalized by size factor and replicates
for each time point added together.
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Functional annotation of cluster 2
Figure 1.16: Full set of Reactome terms enriched in cluster #2 with respect to
the other clusters (FDR ≤ 0.05). Annotation similarity indicates what fraction
of genes (based upon the term associated with less genes) are shared between
two terms.
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Functional annotation of cluster 3
Figure 1.17: Full set of Reactome terms enriched in cluster #3 with respect to
the other clusters (FDR ≤ 0.05). Annotation similarity indicates what fraction
of genes (based upon the term associated with less genes) are shared between
two terms.
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Figure 1.18: Celastrol inhibits cell proliferation. (A) Images of cell cultures
over 4 days, two replicates of three conditions: untreated, DMSO, and 3µM
celastrol. (B) Number of live cells in each cell culture as counted by an automatic
cell counter (TC20, Bio-Rad).
50
The citric acid (TCA) cycle and respiratory electron
transport
Respiratory electron transport
Respiratory electron transport, ATP synthesis by
chemiosmotic coupling, and heat production by uncoupling
proteins.
Mitochondrial translation termination
Mitochondrial translation initiation
Mitochondrial translation
Mitochondrial translation elongation
Viral Messenger RNA Synthesis
Regulatory RNA pathways
Transcriptional regulation by small RNAs
SUMOylation of DNA damage response and repair proteins
SUMO E3 ligases SUMOylate target proteins
SUMOylation
Interactions of Vpr with host cellular proteins
Vpr−mediated nuclear import of PICs
Nuclear Envelope Breakdown
Nuclear Pore Complex (NPC) Disassembly
Glucose transport
Hexose transport
Transport of Ribonucleoproteins into the Host Nucleus
Rev−mediated nuclear export of HIV RNA
Regulation of Glucokinase by Glucokinase Regulatory Protein
Nuclear import of Rev protein
NEP/NS2 Interacts with the Cellular Export Machinery
Interactions of Rev with host cellular proteins
Export of Viral Ribonucleoproteins from Nucleus
Host Interactions of HIV factors
Metabolism of non−coding RNA
snRNP Assembly
Transport of the SLBP independent Mature mRNA
Transport of the SLBP Dependant Mature mRNA
Transport of Mature mRNA derived from an Intron−Containing
Transcript
Transport of Mature Transcript to Cytoplasm
Transport of Mature mRNA Derived from an Intronless
Transcript
Transport of Mature mRNAs Derived from Intronless
Transcripts
Endosomal Sorting Complex Required For Transport (ESCRT)
Tat−mediated HIV elongation arrest and recovery
Pausing and recovery of Tat−mediated HIV elongation
Pausing and recovery of HIV elongation
Late Phase of HIV Life Cycle
HIV Life Cycle
HIV Infection
Elongation arrest and recovery
HIV elongation arrest and recovery
mRNA Capping
Transcription of the HIV genome
Transcription
Tat−mediated elongation of the HIV−1 transcript
RNA Polymerase II Transcription Elongation
RNA Polymerase II Transcription
RNA Polymerase II Pre−transcription Events
HIV Transcription Elongation
Gene Expression
Formation of the HIV−1 Early Elongation Complex
Formation of the Early Elongation Complex
Formation of RNA Pol II elongation complex
Formation of HIV elongation complex in the absence of HIV
Tat
Abortive elongation of HIV−1 transcript in the absence of
Tat
Formation of HIV−1 elongation complex containing HIV−1 Tat
RNA Polymerase II Transcription Termination
Post−Elongation Processing of the Transcript
Post−Elongation Processing of Intron−Containing pre−mRNA
Cleavage of Growing Transcript in the Termination Region
mRNA 3'−end processing
Processing of Capped Intron−Containing Pre−mRNA
mRNA Splicing − Minor Pathway
mRNA Splicing
mRNA Splicing − Major Pathway
10.50
Annotation Similarity
Fu
nc
tio
na
l A
nn
ot
at
io
n
Functional annotation of cluster 4
1 2 3 4 5 6 7
OR
Figure 1.19: Full set of Reactome terms enriched in cluster #4 with respect to
the other clusters (FDR ≤ 0.05). Annotation similarity indicates what fraction
of genes (based upon the term associated with less genes) are shared between
two terms.
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Figure 1.20: TFBS regression model with ChIP-seq data. (A) Weights from
the regression model to predict gene expression from ChIP-seq peak scores in
K562 cells. A positive weight for a TF at given timepoint means that genes at
which that TF is predicted to bind in the promoter region showed increased
expression relative to those without binding by that TF. Negative weights mean
the opposite. Time-point specific TF coefficients explain v 15% of the residual
variance not explained by gene-specific or time-point-specific terms. (B) Pre-
celastrol treatment ChIP-seq signal for RFX1 grouped by clustering based on
expression profiles. Each line represents an average over all genes in the cluster
in the region of the TSS, with lighter-colored bands representing 95% confidence
intervals obtained by bootstrap sampling. (C) Same as (B) but for RFX5.
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Figure 1.21: Increased pausing at promoters is pervasive and broadly anti-
correlated with gene expression. (A) Heatmap of fold-change in read counts
near promoters of all protein coding genes relative to the 0-minute time point.
Numbers at top indicate minutes after celastrol treatment. (B) Histogram of per-
gene Pearson correlations between log pause index (LPI) and gene expression.
Cluster labeling is from the clustering of gene expression profiles in Figure 3.
For most genes, pausing and expression are anti-correlated, but cluster #1 has a
long tail of genes with correlations near, or greater than 0.
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Figure 1.22: Heat shock induces a similar, but more pronounced, response
than celastrol. (A) Pearson correlation of gene expression after 30 minutes of
heat shock (Vivevaara et al., in press) with gene expression at each time-point
after celastrol treatment. Error bars represent 95% CIs of the mean computed us-
ing Fisher’s method for computing errors of Pearson correlation coefficients. (B)
Distribution of fold changes in gene expression after 30 minutes of heat shock
vs. after 40 minutes of celastrol treatment. (C) Distribution of log fold pause
indices for all active genes at each time point during heat shock.
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Downregulated: HS & Celastrol(C)
Figure 1.23: The shared repressive celastrol and heatshock response is domi-
nated by translation and nonsense mediated decay. (A) Enrichment of celastrol
(40 min.) specific repressed genes relative to all repressed genes (FDR ≤ 0.05).
(B) Enrichment of heat shock (30 min.) specific repressed genes relative to all
repressed genes (FDR ≤ 0.05). (C) Enrichment of genes repressed in both the
heat shock and celastrol treatments relative to all repressed genes (FDR ≤ 0.05).
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Figure 1.24: The shared celastrol and heat-shock response for up-regulated
genes is dominated by the HSF response. (A) Enrichment of heat shock (30
min.)-specific activated genes relative to all activated genes (FDR ≤ 0.05). (B)
Enrichment of genes repressed in both the heat shock and celastrol responses
relative to all repressed genes (FDR ≤ 0.05).
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Figure 1.25: Heat shock and celastrol have opposite effects cholesterol biosyn-
thesis associated genes. (A) Log2 fold-changes in expression in the celastrol
(left) and heat shock (right) responses of genes that are involved in cholesterol
biosynthesis and that are differentially expressed in at least one sample (FDR ≤
0.01). (B) Log2 fold-change expression of genes stratified by status of ChIP-seq
signal for SREBF1 within 500bp of the promoter, based on ChIP-seq data for un-
treated K562 cells from ENCODE. Low: <20th percentile; Medium: 20th–80th
percentile; High: > 80th percentile in peak intensity.
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Figure 1.26: Increased pausing at enhancers is pervasive. Heatmap of fold-
change in read counts relative to the 0-minute time point near all enhancers.
Numbers at top indicate minutes after celastrol treatment.
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Figure 1.27: A subset of transcription factors is associated with enhancer acti-
vation. Activated enhancers are those that were not transcribed pre-celastrol
treatment but were strongly up-regulated at some point in the time course
whereas unchanged enhancers showed no change in expression throughout the
whole time course (matched for average expression level). DeepBind scores
are computed per TF per enhancer. The notch corresponds to median +/−
1.58 · IQR/√n, roughly a 95% confidence interval of the median.
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1.7 Supplemental Tables
Table 1.1: Distribution of marginal F-statistics and p-values for each motif in
the TF regression using DeepBind scores. F-statistics were computed per motif
scores (there may be multiple motifs for the same TF), summing over the effects
across all time points.
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ID TF F p
D00504.005 MAX 50.8 0.019
D00328.018 CTCF 30.3 0.032
D00471.002 HSF2 25.5 0.038
D00470.005 HSF1 23.7 0.041
D00619.003 RFX5 18.0 0.054
D00363.003 ELK4 15.6 0.062
D00760.003 FOS 13.9 0.069
D00660.005 SRF 13.3 0.072
D00587.002 POU2F1 12.5 0.076
D00789.003 NFYB 12.3 0.077
D00382.003 ETV4 12.0 0.079
D00347.005 E2F4 11.0 0.086
D00687.001 TFEB 10.8 0.087
D00384.002 ETV6 10.8 0.088
D00318.001 CEBPD 9.4 0.100
D00785.001 MYC 9.3 0.100
D00710.007 YY1 9.2 0.101
D00363.004 ELK4 8.6 0.109
Continued on next column
ID TF F p
D00535.004 NFE2 7.9 0.117
D00650.005 SP1 7.9 0.118
D00776.005 JUND 7.7 0.119
D00423.005 GMEB2 7.5 0.122
D00317.003 CEBPB 7.2 0.128
D00817.001 TBP 7.0 0.131
D00799.001 REST 7.0 0.132
D00379.001 ETV1 6.8 0.134
D00756.007 EZH2 6.4 0.142
D00560.003 NRL 6.4 0.143
D00821.001 TRIM28 6.2 0.146
D00559.001 NRF1 6.2 0.147
D00777.002 JUN 6.0 0.151
D00409.004 GABPA 6.0 0.152
D00700.001 USF1 5.9 0.154
D00616.002 RFX3 5.6 0.159
D00686.002 TFE3 5.5 0.162
D00822.001 UBTF 5.5 0.162
D00356.010 ELF1 5.5 0.164
D00504.002 MAX 5.3 0.168
Continued on next column
63
ID TF F p
D00487.003 JDP2 5.3 0.169
D00808.004 SMC3 5.2 0.172
D00739.001 ATF3 5.1 0.175
D00796.001 RAD21 5.0 0.177
D00815.001 TAL1 4.9 0.179
D00813.009 TAF1 4.7 0.187
D00442.003 HMX3 4.7 0.189
D00501.003 MAFF 4.6 0.192
D00825.001 ZBTB33 4.5 0.193
D00501.004 MAFF 4.5 0.195
D00507.002 MEF2D 4.4 0.198
D00709.002 XBP1 4.4 0.199
D00768.001 GTF2F1 4.3 0.201
D00766.002 GATA2 4.3 0.203
D00816.001 TBL1XR1 4.3 0.204
D00672.001 TCF3 4.1 0.209
D00417.005 GCM1 4.1 0.211
D00748.001 CBX3 4.0 0.213
D00755.003 EP300 3.8 0.224
D00606.002 PRRX2 3.8 0.225
Continued on next column
ID TF F p
D00761.001 FOXA1 3.8 0.226
D00755.005 EP300 3.7 0.228
D00805.001 SIRT6 3.7 0.232
D00613.002 RAX 3.5 0.241
D00780.001 KDM5B 3.4 0.247
D00394.003 FOXD2 3.4 0.249
D00505.003 MEF2A 3.4 0.250
D00361.001 ELK3 3.3 0.252
D00433.003 HEY2 3.3 0.257
D00753.001 CTCFL 3.2 0.257
D00807.001 SMARCB1 3.2 0.260
D00292.001 ALX4 3.1 0.266
D00582.001 PITX3 3.1 0.269
D00700.006 USF1 3.0 0.271
D00765.001 GATA1 3.0 0.271
D00483.001 IRX5 3.0 0.274
D00537.001 NFIB 2.9 0.278
D00758.001 FOSL1 2.9 0.279
D00685.003 TFCP2 2.9 0.282
D00475.006 IRF3 2.8 0.287
Continued on next column
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Table 1.1 (Continued)
ID TF F p
D00503.014 MAFK 2.8 0.289
D00323.002 CPEB1 2.8 0.290
D00492.003 LEF1 2.8 0.292
D00317.009 CEBPB 2.7 0.299
D00714.003 ZBTB7A 2.6 0.304
D00353.005 EGR2 2.6 0.306
D00383.002 ETV5 2.5 0.312
D00546.003 NKX3-1 2.5 0.320
D00673.001 TCF4 2.5 0.321
D00395.002 FOXD3 2.4 0.322
D00824.001 WRNIP1 2.4 0.324
D00632.001 SHOX2 2.4 0.329
D00630.003 SCRT1 2.3 0.338
D00626.005 RXRA 2.3 0.342
D00356.005 ELF1 2.3 0.343
D00404.002 FOXO1 2.3 0.343
D00762.001 FOXA2 2.2 0.345
D00592.003 POU3F2 2.2 0.350
D00691.001 TGIF2 2.2 0.353
D00421.003 GLIS2 2.2 0.353
Continued on next column
ID TF F p
D00787.002 NFIC 2.1 0.358
D00581.002 PITX1 2.1 0.365
D00490.003 KLF16 2.0 0.371
D00468.003 HOXD8 2.0 0.373
D00660.007 SRF 2.0 0.373
D00779.001 KDM5A 2.0 0.376
D00538.001 NFIL3 2.0 0.381
D00678.001 TEAD3 1.9 0.391
D00559.006 NRF1 1.9 0.394
D00677.003 TEAD1 1.8 0.399
D00774.001 IKZF1 1.8 0.403
D00324.003 CREB3L1 1.8 0.404
D00818.003 TCF12 1.8 0.404
D00626.009 RXRA 1.8 0.411
D00409.003 GABPA 1.7 0.417
D00512.001 MEIS3 1.7 0.418
D00326.002 CREB3 1.7 0.422
D00601.003 PRDM4 1.7 0.424
D00398.001 FOXJ2 1.7 0.427
D00663.002 TBX15 1.7 0.430
Continued on next column
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Table 1.1 (Continued)
ID TF F p
D00293.003 ARNTL 1.6 0.440
D00654.003 SPDEF 1.6 0.440
D00408.003 FOXP3 1.6 0.440
D00680.001 TEF 1.6 0.441
D00600.004 PRDM1 1.6 0.448
D00752.001 CTBP2 1.6 0.449
D00812.001 SUZ12 1.5 0.451
D00345.002 E2F2 1.5 0.452
D00328.003 CTCF 1.5 0.469
D00577.002 PAX9 1.5 0.471
D00523.003 MSC 1.4 0.472
D00782.001 MEF2C 1.4 0.473
D00529.004 MYBL2 1.4 0.480
D00529.001 MYBL2 1.4 0.481
D00405.003 FOXO3 1.4 0.483
D00653.003 SP8 1.4 0.487
D00488.003 KLF13 1.4 0.487
D00407.003 FOXO6 1.3 0.493
D00652.004 SP4 1.3 0.495
D00769.001 HDAC1 1.3 0.497
Continued on next column
ID TF F p
D00368.007 EN2 1.3 0.498
D00304.003 BATF3 1.3 0.499
D00763.001 FOXM1 1.3 0.499
D00321.003 CENPB 1.3 0.500
D00320.001 CEBPG 1.3 0.509
D00364.002 EMX1 1.3 0.513
D00547.003 NKX3-2 1.3 0.515
D00540.002 NFKB1 1.3 0.517
D00406.002 FOXO4 1.3 0.517
D00614.001 RFX2 1.2 0.520
D00552.006 NR2C2 1.2 0.526
D00631.002 SCRT2 1.2 0.532
D00750.001 CHD1 1.2 0.536
D00539.001 NFIX 1.2 0.536
D00788.001 NFYA 1.2 0.537
D00770.002 HDAC2 1.2 0.538
D00704.001 VDR 1.2 0.540
D00344.005 E2F1 1.1 0.548
D00508.004 MEIS1 1.1 0.552
D00430.003 HES7 1.1 0.557
Continued on next column
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Table 1.1 (Continued)
ID TF F p
D00810.001 STAT3 1.1 0.559
D00744.001 BCLAF1 1.1 0.561
D00349.002 E2F8 1.1 0.570
D00652.003 SP4 1.1 0.570
D00575.003 PAX6 1.1 0.572
D00459.003 HOXC10 1.0 0.579
D00461.003 HOXC12 1.0 0.581
D00619.007 RFX5 1.0 0.586
D00783.001 MTA3 1.0 0.590
D00809.002 SP2 1.0 0.593
D00340.003 DMBX1 1.0 0.594
D00651.003 SP3 1.0 0.594
D00746.004 BHLHE40 1.0 0.598
D00429.003 HES5 1.0 0.602
D00335.003 DLX2 0.9 0.608
D00692.002 THRA 0.9 0.611
D00329.002 CUX1 0.9 0.613
D00689.003 TGIF1 0.9 0.616
D00416.005 GBX2 0.9 0.618
D00655.002 SPI1 0.9 0.625
Continued on next column
ID TF F p
D00381.003 ETV3 0.9 0.631
D00771.001 HDAC6 0.9 0.633
D00396.003 FOXG1 0.9 0.635
D00819.002 TCF7L2 0.9 0.640
D00435.003 HIC2 0.8 0.647
D00503.004 MAFK 0.8 0.648
D00348.003 E2F7 0.8 0.649
D00533.003 NFAT5 0.8 0.651
D00558.002 NR4A2 0.8 0.652
D00655.006 SPI1 0.8 0.664
D00370.003 ERF 0.8 0.671
D00522.002 MNX1 0.8 0.671
D00591.002 POU3F1 0.8 0.674
D00351.001 EGR1 0.8 0.676
D00299.003 ATF7 0.8 0.679
D00510.003 MEIS2 0.8 0.680
D00801.001 SAP30 0.7 0.693
D00794.047 POLR2A 0.7 0.693
D00542.005 NHLH1 0.7 0.701
D00366.003 EN1 0.7 0.703
Continued on next column
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Table 1.1 (Continued)
ID TF F p
D00424.002 GRHL1 0.7 0.703
D00611.001 RARG 0.7 0.707
D00710.002 YY1 0.7 0.715
D00740.002 BACH1 0.7 0.720
D00695.002 TP63 0.6 0.735
D00441.003 HMX2 0.6 0.739
D00759.001 FOSL2 0.6 0.748
D00412.002 GATA5 0.6 0.749
D00681.002 TFAP2A 0.6 0.752
D00775.001 JUNB 0.6 0.758
D00600.001 PRDM1 0.6 0.767
D00741.001 BATF 0.6 0.772
D00642.003 SOX18 0.5 0.778
D00541.001 NFKB2 0.5 0.779
D00565.002 ONECUT2 0.5 0.782
D00524.002 MSX1 0.5 0.786
D00754.003 E2F6 0.5 0.793
D00747.001 BRCA1 0.5 0.796
D00337.001 DLX4 0.5 0.803
D00351.006 EGR1 0.5 0.804
Continued on next column
ID TF F p
D00318.004 CEBPD 0.5 0.809
D00635.001 SMAD3 0.5 0.813
D00489.002 KLF14 0.5 0.814
D00519.002 MLXIPL 0.5 0.819
D00401.003 FOXK1 0.5 0.820
D00484.003 ISL2 0.5 0.826
D00516.002 MESP1 0.5 0.827
D00664.002 TBX19 0.4 0.829
D00705.003 VENTX 0.4 0.833
D00772.001 HMGN3 0.4 0.847
D00713.003 ZBTB49 0.4 0.850
D00583.002 PKNOX1 0.4 0.851
D00743.001 BCL3 0.4 0.852
D00662.003 TBR1 0.4 0.853
D00506.003 MEF2B 0.4 0.857
D00393.003 FOXC2 0.4 0.881
D00784.004 MXI1 0.3 0.885
D00595.001 POU4F1 0.3 0.888
D00495.003 LHX6 0.3 0.890
D00749.001 CCNT2 0.3 0.893
Continued on next column
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Table 1.1 (Continued)
ID TF F p
D00792.001 PHF8 0.3 0.900
D00665.002 TBX1 0.3 0.902
D00599.006 POU6F2 0.3 0.902
D00767.001 GTF2B 0.3 0.903
D00802.001 SETDB1 0.3 0.905
D00681.004 TFAP2A 0.3 0.916
D00478.003 IRF7 0.3 0.923
D00344.002 E2F1 0.3 0.927
D00790.001 NR2F2 0.3 0.928
D00556.003 NR3C1 0.3 0.930
D00535.003 NFE2 0.3 0.937
D00432.003 HEY1 0.2 0.940
D00410.009 GATA3 0.2 0.950
D00351.009 EGR1 0.2 0.954
D00623.003 RUNX2 0.2 0.963
D00347.003 E2F4 0.2 0.965
D00552.002 NR2C2 0.2 0.969
D00517.002 MGA 0.2 0.970
D00346.003 E2F3 0.2 0.971
D00410.003 GATA3 0.2 0.975
Continued on next column
ID TF F p
D00305.003 BCL6B 0.2 0.976
D00418.003 GCM2 0.2 0.979
D00650.007 SP1 0.2 0.979
D00745.001 BDP1 0.1 0.987
D00791.001 PBX3 0.1 0.988
D00505.006 MEF2A 0.1 0.990
D00797.001 RBBP5 0.1 0.993
D00536.003 NFIA 0.1 0.994
D00793.002 PML 0.1 0.997
D00475.003 IRF3 0.1 0.997
D00528.001 MYBL1 0.1 0.997
D00679.004 TEAD4 0.1 0.998
D00431.002 HESX1 0.0 1.000
Concluded
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Table 1.1 (Continued)
Table 1.2: Distribution of the marginal F-statistics and p-values for each motif
in the TF regression using ChIP-seq scores. F-statistics were computed per
motif scores (there may be multiple motifs for the same TF), summing over the
effects across all time points.
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TF F p
POLR2A 227.6 0.004
MYC 77.6 0.013
RFX1 67.4 0.015
TBP 49.3 0.020
CCNT2 45.8 0.022
UBTF 43.6 0.023
RAD21 40.8 0.024
E2F4 35.1 0.028
PHF8 34.8 0.028
SP1 32.5 0.030
PML 30.3 0.032
MXI1 30.2 0.032
SUZ12 25.3 0.039
CHAMP1 25.2 0.039
RCOR1 24.2 0.040
MLLT1 23.5 0.041
MAX 23.0 0.042
SAP30 21.9 0.044
Continued on next column
TF F p
C11orf30 21.0 0.046
NFYA 20.5 0.047
HDAC1 18.5 0.052
ZBTB40 16.6 0.058
ZBTB33 16.1 0.060
ESRRA 15.9 0.060
NFYB 15.7 0.061
ZNF318 15.5 0.062
GTF2B 12.9 0.074
ELF1 12.9 0.074
ATF1 12.8 0.074
RAD51 12.3 0.077
TRIM24 12.0 0.079
YY1 11.8 0.080
L3MBTL2 11.4 0.083
SMAD5 11.2 0.084
COPS2 10.6 0.089
RBBP5 10.5 0.090
CREM 9.7 0.097
IRF2 9.6 0.098
Continued on next column
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TF F p
CEBPZ 9.2 0.101
TAF1 9.0 0.104
BMI1 8.1 0.114
MAZ 8.1 0.114
GABPA 7.6 0.122
NFE2 7.5 0.124
BACH1 7.2 0.127
TEAD4 7.1 0.130
YBX1 7.0 0.130
USF1 7.0 0.131
TARDBP 6.6 0.139
GATA1 6.6 0.139
NRF1 6.5 0.140
HDAC2 6.2 0.145
FOXK2 6.2 0.146
ATF3 6.2 0.146
CHD1 6.2 0.146
GTF3C2 6.1 0.149
PKNOX1 6.0 0.151
CTCFL 6.0 0.151
Continued on next column
TF F p
SIN3A 5.9 0.153
SMARCA4 5.8 0.156
SMARCA5 5.7 0.157
GATA2 5.7 0.158
SREBF1 5.6 0.159
MAFK 5.5 0.163
SIX5 5.5 0.163
TAF7 5.4 0.164
ZNF143 5.4 0.166
SP2 5.0 0.177
EP300 4.9 0.179
BDP1 4.9 0.181
CTCF 4.9 0.181
RNF2 4.8 0.184
SRF 4.8 0.185
KDM5B 4.7 0.186
ZBTB7A 4.7 0.188
ZHX1 4.5 0.196
FOS 4.1 0.210
TRIM28 4.0 0.216
Continued on next column
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Table 1.2 (Continued)
TF F p
EGR1 4.0 0.216
ZBTB11 3.9 0.218
CEBPB 3.9 0.220
E2F6 3.8 0.223
NFRKB 3.8 0.226
CDC5L 3.7 0.228
DPF2 3.6 0.236
GTF2F1 3.5 0.242
SETDB1 3.4 0.246
EZH2 3.3 0.251
HDGF 3.1 0.268
SMARCB1 2.9 0.278
CBX3 2.9 0.284
RUNX1 2.9 0.284
POLR3G 2.8 0.289
HDAC6 2.7 0.302
ARID3A 2.6 0.303
NR2F6 2.6 0.309
NR2C2 2.6 0.309
CHD2 2.4 0.326
Continued on next column
TF F p
SPI1 2.4 0.328
NBN 2.4 0.332
DDX20 2.2 0.348
IKZF1 2.2 0.349
REST 2.2 0.356
MEF2A 2.1 0.366
STAT5A 2.0 0.374
TCF7 2.0 0.375
MAFF 2.0 0.379
BCLAF1 1.9 0.386
POLR3A 1.9 0.389
BHLHE40 1.9 0.391
MIER1 1.9 0.396
YBX3 1.8 0.407
KDM1A 1.8 0.410
MYNN 1.7 0.416
THAP1 1.6 0.449
MCM3 1.5 0.461
JUN 1.5 0.467
ZEB2 1.5 0.469
Continued on next column
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Table 1.2 (Continued)
TF F p
SMC3 1.4 0.480
ETV6 1.4 0.487
KLF16 1.3 0.498
HES1 1.3 0.504
TAL1 1.3 0.505
BCOR 1.2 0.522
TBL1XR1 1.2 0.535
ELK1 1.2 0.536
SMARCE1 1.1 0.570
CBX5 1.0 0.577
NR2F2 1.0 0.585
ZMIZ1 0.9 0.609
FOSL1 0.9 0.618
MCM7 0.9 0.642
MBD2 0.8 0.645
ZNF24 0.8 0.648
DEAF1 0.8 0.650
MITF 0.8 0.668
MCM5 0.8 0.671
SMAD2 0.8 0.678
Continued on next column
TF F p
ARNT 0.7 0.692
BRF2 0.7 0.714
JUNB 0.7 0.717
NCOA1 0.6 0.735
ZNF274 0.6 0.742
KAT8 0.6 0.753
JUND 0.6 0.760
MTA2 0.4 0.878
SIRT6 0.4 0.880
USF2 0.3 0.885
ZNF263 0.2 0.960
LEF1 0.1 0.983
CBX1 0.1 0.987
ZKSCAN1 0.1 0.990
RFX5 0.0 1.000
HMBOX1 0.0 1.000
HMGN3 0.0 1.000
KDM4B 0.0 1.000
Concluded
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Table 1.2 (Continued)
CHAPTER 2
IS A SUPER-ENHANCER GREATER THAN THE SUM OF ITS PARTS?
Note: With the exception of the preface, the introduction, and few minor
changes, this chapter contains the same text as the previously published work
“Is a super-enhancer greater than the sum of its parts?” in Nature Genetics (Vol-
ume 49, Number 1).
2.1 Preface
This chapter is somewhat unusual, both in its origin and its brevity. It was
conceived of based on a comparison between two papers, Shin et al. (2016)
and Hay et al. (2016), during a lab journal club. This discussion convinced Dr.
Brad Gulko to do some preliminary analysis the following weekend, and see-
ing promising results, the three first authors jointly performed the work for the
super-enhancer paper. In early 2018, based on requests from other groups for
help performing similar analysis, the author of this thesis wrote the superEn-
hancerModelR R package (Dukler, 2018).
2.2 Introduction
The first enhancer was described in 1980, based on deletion studies of a 72-bp
sequence in Simian Virus 40 genome (Benoist and Chambon, 1981; Gruss et al.,
1981). Shortly thereafter, an example was found in mammalian cells and the
ability of enhancers to act in a distance independent fashion was established
(Banerji et al., 1983; Gillies et al., 1983; Mercola et al., 1983). Given that enhancers
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could be quite far from the gene that they regulated, locating them could be a
major challenge. The first next major advance on this front came during the
early short read sequencing era, when work from Gregory Crawford’s and Bing
Ren’s groups discovered that the histone H3K4me1 modification and p300 bind-
ing were indicative of enhancer function (Heintzman et al., 2007). Shortly there-
after additional genomic signatures of enhancers were identified, which further
facilitated genome-wide enhancer discovery (Heintzman et al., 2009; De Santa
et al., 2010; Kim et al., 2010).
The term “super-enhancer” was coined by Whyte et al. (2013) to describe
their observation that a small fraction of enhancers were strongly enriched for
binding master regulators (Oct4, Sox2, Nanog) and Mediator (Med1), and that
these elements seemed to regulate cellular identity. Additional work charac-
terizing super-enhancers suggested that they also played an important role in
disease (Hnisz et al., 2013, 2015; Vahedi et al., 2015). As papers about super-
enhancers proliferated (from 15 in 2013 to 182 in 20161), so did ways of detect-
ing and defining them. For example, Hnisz et al. (2013) used H3K27Ac signal,
not TF binding, to locate individual enhancers, and H3K27Ac enrichment in-
stead of Med1 enrichment to filter for super-enhancers. Independently Parker
et al. (2013) described a similar concept, the “stretch-enhancer”, characterized
by long regions of chromatin (≥ 3kb) with an enhancer signature. Like super-
enhancers, “stretch-enhancers” showed a tendency to be cell type specific and
enrich for disease variants (Parker et al., 2013; Quang et al., 2015). Despite their
similarities “super-enhancers” and “stretch-enhancers” had several notable dif-
ferences including there being an order of magnitude more “stretch-enhancers”
than “super-enhancers”, leading to debate in the community about whether ei-
1Based on Web of Science search for term “super-enhancer”
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ther concept represented a truly novel mechanism of gene regulation beyond
the existing enhancer literature (Pott and Lieb, 2015).
By this point a large body of evidence had accumulated that enhancers
played a key role in both development and disease (Smith and Shilatifard, 2014).
Combined with recent developments in gene editing technology (TALENs,
CRISPR), this led to a wave of studies attempting to characterize these elements
in vivo (Canver et al., 2015; Shin et al., 2016; Hay et al., 2016; Moorthy et al., 2017).
Two of these studies, Shin et al. (2016) and Hay et al. (2016), focused on the
Wap and α-globin respectively, which were well characterized and thus valuable
model systems. The α-globin locus contains HBZ (ζ-hemoglobin), HBA2 (α2-
hemoglobin), HBA1 (α1-hemoglobin) and HBQ1 (θ-hemoglobin) genes which
are specifically expressed in erythroid cells. Previous work on this region had
shown evidence of multiple distal cis-regulatory elements under selective pres-
sure (Hughes et al., 2005) that looped to α-globin promoters (Hughes et al.,
2014). The Wap super-enhancer is able to induce the Wap gene, which code
for a core whey protein (Simpson et al., 2000), over 1000-fold specifically in
mammary tissue during pregnancy (Burdon et al., 1991). Given the controversy
over the nature of super-enhancers, the enhancer-dependant inducibility and
cell type specificity of both loci made them obvious candidates for dissecting
the “super-enhancer” concept.
2.3 Letter to the editor
The recent back-to-back articles by Hay et al. (2016) and Shin et al. (2016) both
addressed the important question of how the constituent enhancers of a so-
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called “super-enhancer” combine to activate the expression of a target gene.
Super-enhancers are collections of closely spaced genomic regions that exhibit
hallmarks of enhancers, such as binding by the Mediator complex and acetyla-
tion of histone H3 at lysine 27 (H3K27ac)(Hnisz et al., 2013; Whyte et al., 2013;
Heinz et al., 2015). As these authors noted, there is continuing controversy over
whether super-enhancers genuinely represent a new paradigm in transcrip-
tional regulation or whether they may essentially just be clusters of conven-
tional enhancers that together produce a strong transcriptional response(Pott
and Lieb, 2015).
At the heart of this question is whether the activity of a super-enhancer
is simply given by the sum of its constituent enhancers—that is, whether it
is additive—or whether these components instead exhibit some kind of syn-
ergy. Indeed, this question of additivity is of general interest, whether or not
super-enhancers are qualitatively distinct from other loci. Hay et al. (2016) and
Shin et al. (2016) addressed this question by carefully dissecting the highly ex-
pressed α-globin and Wap loci , respectively, andmeasuring the reductions in
gene expression resulting from several individual and combined knockouts of
constituent enhancers. Both articles described highly variable effects on gene
expression from different individual knockout experiments, and both reported
that it was necessary to disable multiple enhancers to abolish, or nearly abolish,
expression. On the question of additivity, however, the two articles reached
strikingly different conclusions: Hay et al. reported that the constituent en-
hancers at the α-globin locus acted “independently and in an additive fashion,”
whereas Shin et al. reported that their observations of the Wap super-enhancer
supported a “temporal and functional hierarchy” of constituent enhancers that
is presumably non-additive.
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It was notable that neither of these articles offered a precise definition for
“additivity” or “hierarchy”. Moreover, neither article explicitly compared a
null hypothesis of additivity against an alternative hypothesis. In reviewing
these two works, we became interested in the various ways in which a super-
enhancer’s activity could plausibly be modeled using a linear function of the
activity of its constituent enhancers, possibly together with a simple nonlinear
“link” function(Nelder and Wedderburn, 1972), and in whether the data would
allow a null hypothesis of such generalized linearity to be formally rejected.
Here we show, by reanalyzing these two data sets, that they are both consistent
with a generalized linear model that has a simple biophysical interpretation and
does not require any hierarchy or synergy among constituent enhancers. Thus,
we argue that it still remains to be demonstrated that a super-enhancer is greater
than the sum of its parts.
Perhaps the simplest linear model would assume each constituent enhancer
makes an additive contribution directly to the expression level of the target
gene, such as might be the case if the constituent enhancers separately con-
tribute to transcription. (This appears to be the model that Hay et al. (2016)
had in mind.) Specifically, let us define the “activity” of the super-enhancer by
the affine (linear plus constant) function,
A(x) = β0 + β1x1 + β2x2 + · · · + βnxn, (2.1)
where x = (x1, . . . , xn)′ is a vector of binary variables indicating whether each
constituent enhancer xi is present (xi = 1) or absent (xi = 0) and β = (β1, . . . , βn)′ is
a corresponding vector of real-valued coefficients, with β0 as an intercept term.
Then, we can model measurements of the expression of the target gene, R(x),
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as a combination of this activity function and a variable  representing some
combination of biological and experimental noise.
Thus, we write,
R(x) = A(x) + . (additive model) (2.2)
In practice, we consider alternative noise models and find that a log-normal
model fits the data best for all of the models that we consider (see Supplemen-
tary Note for details).
Another plausible scenario is that the constituent enhancers combine multi-
plicatively, rather than additively, in determining R(x). This multiplicative re-
lationship might be expected, say, if the constituent enhancers act to promote
transcription in a sequential manner, with each step having the opportunity to
amplify or dampen the outputs of previous steps. This relationship can be cap-
tured simply by making R(x) an exponential, rather than an additive, function
of the activity A(x). Because the scale of A(x) is determined by free parameters,
the base associated with the exponent is unimportant. By convention, we use
base e and write,
R(x) = eA(x) + . (linear-exponential model) (2.3)
Equation 2.3 can be considered a generalized linear model with inverse link
function ex (in the language of GLMs (Nelder and Wedderburn, 1972)). Im-
portantly, it is fully determined by a linear activity function, with no explicit
consideration of interactions between the constituent enhancers.
Notably, this model can be given an alternative biophysical interpretation.
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Let us assume a physical system with two broadly defined “states,” a low-
energy state associated with active transcription and a higher-energy baseline
state. (The model is abstract: in reality, these “states” may each correspond
to large ensembles of particular configurations of molecules.) Furthermore, let
us interpret A(x) as a measure of the reduction in energy of the transcription-
associated state relative to the baseline state. Statistical mechanics tells us that
the occupancy of the low-energy state should be given by a Boltzmann distribu-
tion and be proportional to eA(x)/Z, where Z is the partition function. If we fur-
ther assume that the system is far from its optimum, then the occupancy of the
low-energy state will be approximately proportional to eA(x). Equation 2.3 can
therefore be interpreted as the model that results from assuming transcription
is proportional to occupancy of the low-energy state in this suboptimal regime.
This physical interpretation, with a two-state system and a linear energy
function, leads naturally to a third generalized linear model. In this case,
we abandon the “suboptimal” approximation and consider the full Boltz-
mann distribution for the system(La¨ssig, 2007; Phillips, 2015). In the two-
state model, we can explicitly calculate the partition function Z and write,
eA(x)/Z = eA(x)/
(
1 + eA(x)
)
= 1/
(
1 + e−A(x)
)
, which is known as a logistic function
of A(x). Thus, we can fully describe the fraction of time the low-energy state
is occupied using a generalized linear model with the logistic function as the
inverse link function. Assuming again that gene expression is proportional to
the occupancy of the low-energy state, we write,
R(x) =
γ
1 + e−A(x)
+ , (linear-logistic model) (2.4)
where γ defines the maximum expected level of gene expression (for a similar
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model applied to enhancers, see Crocker et al. (2016)). Equation 2.4 will behave
similarly to equation 2.3 when A(x) is far from its optimum but it will capture
the phenomenon of diminishing returns in transcriptional output as the ener-
getics of productive transcriptional elongation approach an optimum and gene
expression is limited by other features of the system (saturation).
We fitted these three models (equations 2.2–2.4) to the raw data from Hay
et al. (2016) and Shin et al. (2016) by maximum likelihood using a numerical
algorithm for optimization. The data consisted of all replicates for each tested
configuration (wild type and knockout) of the three constituent enhancers of the
Wap super-enhancer and the five constituent enhancers of the α-globin super-
enhancer (see Supplementary Note for complete details). We compared the
goodness-of-fit of the models using the Bayesian Information Criterion (BIC),
which penalizes more complex models for their additional parameters. (Here,
the linear-logistic model has one additional parameter, γ.)
For the α-globin data set (Hay et al., 2016), for which the authors claimed
additivity, we found that the additive model did indeed fit the data fairly well
(Figure 2.1A). Nevertheless, the linear-logistic model was preferred over the ad-
ditive model according to the BIC, despite its additional parameter. For the Wap
data set (Shin et al., 2016), the linear-logistic model is the best-fitting model by
a substantial margin. Thus, for both of these data sets, the linear-logistic model
explains the observed data better than any other generalized linear model (Fig-
ure 2.1B&C), and therefore is a better null model than the additive model. No-
tably, the linear-logistic model explains both data sets well despite several im-
portant differences between the two loci (e.g., the Wap component enhancers
are substantially more tightly clustered and closer to the TSS than those for α-
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globin) and between the knock-out strategies used (Shin et al. deleted STAT5-
binding sites whereas Hay et al. deleted larger DNase-I hypersensitive regions),
which underscores the flexibility and generality of this simple model.
But do the data of Shin et al. (2016) for the Wap super-enhancer truly sup-
port something more complex than a generalized linear relationship, as the au-
thors seem to claim? We attempted to address this question quantitatively in
our framework by introducing interaction terms for the two pairs of constituent
enhancers that were simultaneously knocked out in that study (∆E1a/∆E2 &
∆E2/∆E3). We found that models allowing for interactions between constituent
enhancers do have slightly higher likelihoods than the simple linear-logistic
model, as they must, but, according to the BIC, these improvements are not
sufficient to justify the use of an additional parameter (Figure 2.1D; see Sup-
plementary Note for details). Thus, we find not only that the linear-logistic
model fits both the α-globin and Wap data sets reasonably well, but also that
this model cannot confidently be rejected in favor of one that allows for interac-
tions between constituent enhancers.
It is possible, of course, that interactions between component enhancers do
occur in reality, but the data collected so far are insufficiently abundant or pre-
cise to reject a generalized linear null model. In addition, our models are limited
in that they address only the knockout data from these studies. In particular,
our models do not address Shin et al.’s observation that the E1 enhancer is oc-
cupied by key transcription factors first during pregancy, suggesting possible
non-additivity in temporal establishment of the Wap super-enhancer, if not in
its subsequent regulatory behavior. Finally, it is worth emphasizing that our
abstract modeling approach provides no direct mechanistic insights into tran-
83
Figure 2.1: Comparing model fits for the α-globin and Wap super-
enhancers.(A) Model fit for the α-globin (blue) and Wap (green) data sets, mea-
sured as the Bayesian Information Criterion (BIC) for the additive model minus
the BIC for the additive (0 by definition), linear-exponential, and linear-logistic
models. (B) Predicted expression at the α-globin locus (black line, with blue
boundaries indicating 0.05–0.95 quantiles) under the best-fitting linear-logistic
model. The actual data points are shown in red, with replicates aligned verti-
cally. (C) Same for the Wap locus. In (B) and (C), the wild-type configuration
appears as the collection of data points farthest to the right. Notice that the def-
inition of the x-axis depends on the linear coefficients estimated for each model.
(D) Model fit, measured by BIC, for the Wap data set for the linear-logistic model
shown in (A) relative to alternative models with interaction terms for either E1a
& E2 or E2 & E3
scriptional regulation at either of these loci. Nevertheless, we have shown that
the observed knockout data for both of these super-enhancers can be explained
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fairly well by a very simple generalized linear model, and this observation can
at least constrain the family of possible mechanistic models. More broadly, we
argue that the transcription field would benefit from clearer definitions of null
models and more rigorous criteria for rejecting them before concluding that
complex behaviors occur.
Note: The computer code originally developed for this analysis is available on
GitHub (https://github.com/CshlSiepelLab/super-enhancer-code).
Additionally, since the publication of the original article an R package
has been created and is available at https://github.com/ndukler/
superEnhancerModelR.
2.4 Supplemental Materials
2.4.1 Model design
We designed three models (additive, linear-exponential, and linear-logistic) to
predict gene expression, each as a transformation of an affine function A(x).
With xi as indicator variables for the presence of individual enhancers and βi
as the coefficients that estimate the relative enhancer contributions to gene ex-
pression, the activity function A(x) is written:
A(x) = β0 + β1x1 + β2x2 + · · · + βnxn,
Each model predicts gene expression T (x) as a monotonically increasing
function of A(x): T (x) = g−1(A(x)), where g() is a link function and g−1() is its
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inverse (following the conventions of generalized linear models(Nelder and
Wedderburn, 1972). The measured expression level, R(x), is then assumed to
be a combination of the true level T (x) and some noise  (see next section). The
additive model is simply defined by the identity inverse link function:
T (x) = A(x).
The linear-exponential model is given by:
T (x) = eA(x).
Finally, the linear-logistic model is given by:
T (x) =
γ
1 + e−A(x)
.
2.4.2 Error models
For each generalized linear model we specified normal and log-normal error
models. The normal error model is defined by assuming that:
R(x) = T (x) + ,
where the noise  is normally distributed with mean zero and variance σ2, that
is,  ∼ N(0, σ2). This is equivalent to saying that a measurement of gene expres-
sion for a particular value of x, R(x), is assumed to be normally distributed with
mean T (x) and variance σ2. Thus, the density function for R(x) is:
f (R(x)) =
1
σ
√
2pi
exp
[
− (R(x) − T (x))
2
2σ2
]
.
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By contrast, the log normal error model assumes that the noise is normally
distributed on a log scale, that is,
logR(x) = logT (x) + ,
where, again,  ∼ N(0, σ2). This is equivalent to saying that R(x) has a log-
normal distribution with density function,
f (R(x)) =
1
R(x)σ
√
2pi
exp
[
− (logR(x) − logT (x))
2
2σ2
]
.
We found that the log-normal error model fit the data substantially better
than the normal error model in all cases (Supplemental Fig. ??), and we used
it for all results discussed in the main text. Note that measuring error on a log
scale, as in the log-normal model, makes sense when PCR amplification makes
a large contribution to measurement error, as may be the case for the data from
Shin et al. (2016).
2.4.3 Interaction Parameters
Shin et al. (2016) proposed a “functional hierarchy within the STAT5-driven Wap
super-enhancer”. Within our framework we defined hierarchical relationship
between two enhancers as indicator variables whose state depended jointly on
the presence of both enhancers. To test Shin et al.’s claims, we defined a set of
augmented models that included additional indicator variables xi j (defined for
i < j) where: 
xi j = 1 if xi = 1 ∧ x j = 1
xi j = 0 otherwise
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We created two linear-logistic models with log-normal error, one that in-
cluded x12, and one that included x23. We did not fit a separate model for x13
since there was no data for an E1 − E3 deletion. Each of these models had five
centrality (non-error) parameters. Given that the dataset for the Wap super-
enhancer only contains six conditions, we could not fit multiple interaction
terms at once without over-fitting.
2.4.4 Model optimization
For all three models (additive, linear-exponential, and linear-logistic) we fit two
error models, normal and log-normal, by maximum likelihood. All models were
fit in R using the differential evolutionary algorithm package DEoptim (Mullen
et al., 2011). The variance parameter σ was estimated as well as the coefficients
(β0, . . . , βn). All replicates were considered simultaneously. A population with
20 times as many members as there were parameters was created and run for
10,000 steps. The best solution was then further optimized by running gradi-
ent descent (L-BFGS-B) until convergence. The Bayesian Information Criterion
(BIC) was computed for each model using the formula:
BIC = −2 log(L) + k log(N)
where L is the likelihood of the data with the parameters obtained via optimiza-
tion, k is the number of free parameters, and N is the number of data points.
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2.5 Supplemental Figures
Figure 2.2: Bayesian Information Criterion (BIC) for all models. (A) α-globin
locus. (B) Wap locus.
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Figure 2.3: Additive model with normal and log-normal error models fit to
α-globin locus data. (A) Normal error model. (B) Log-normal error model.
Figure 2.4: Linear-exponential model with normal and log-normal error mod-
els fit to α-globin locus data. (A) Normal error model. (B) Log-normal error
model.
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Figure 2.5: Linear-logistic model with normal and log-normal error models fit
to α-globin locus data. (A) Normal error model. (B) Log-normal error model.
Figure 2.6: Additive model with normal and log-normal error models fit to
Wap locus data. (A) Normal error model. (B) Log-normal error model.
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Figure 2.7: Linear-exponential model with normal and log-normal error mod-
els fit to Wap locus data. (A) Normal error model. (B) Log-normal error model.
Figure 2.8: Linear-logistic model with normal and log-normal error models fit
to Wap locus data. (A) Normal error model. (B) Log-normal error model.
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CHAPTER 3
CHARACTERIZING THE GENOMIC DETERMINANTS OF
CIS-REGULATORY ELEMENT EVOLUTION WITH PHYLOGENETIC
MODELS
3.1 Introduction
Cis-regulatory elements (CREs) govern gene regulation and thereby phenotype
to a large degree, accounting for the vast majority (v 80%) of narrow sense trait
heritability (Gusev et al., 2014). As such, the evolutionary processes that govern
the turnover of these elements have been of intense interest at both mechanistic
and epigenetic levels.
Work using signatures of inter-species sequence conservation in mammals
to locate CREs has estimated that at least 5% of the human genome has under-
gone purifying selection (Lindblad-Toh et al., 2011). However these approaches
suffer from two main limitations: (1) they are unable to resolve the tissue(s) in
which the CRE is active and (2) they have limited power to locate where the
constrained regions actually are, especially in non-coding regions where selec-
tion may be weaker and act on shorter regions. Regions under positive selec-
tion have also been of great interest, with studies in the human lineage finding
human-specific accelerated regions are mostly in non-coding regions (Pollard
et al., 2006), and similar work in eutherian mammals finding evidence of accel-
eration in enhancers associated with neuronal development (Holloway et al.,
2016).
However, it has been shown that comparative sequence based methods may
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be missing a majority of regulatory elements (McGaughey et al., 2008) and
there have been many examples across multiple species of enhancer activity
being conserved without obvious sequence conservation (Fisher et al., 2006;
Yang et al., 2015; Ludwig et al., 2000; Hare et al., 2008). As a result, there has
been considerable interest in predicting enhancer function from sequence (Chen
et al., 2017), to provide a deeper understanding of how mutation at the sequence
level can lead to compensation and maintenance of robust enhancer functional-
ity (Khoueiry et al., 2017; Duque et al., 2014). Most of these studies have focused
on well characterized systems in which either the key TFs or the architecture of
relevant CREs is already known thereby limiting their use in a broader context.
In an attempt to bypass the need for either sequence conservation or lo-
cus specific knowledge, some recent studies have focused on understanding
the genome-wide effects of CRE evolution using epigenetic marks which are
thought to be proxies for regulatory activity. Recent work on DNA methyla-
tion (Qu et al., 2018) used a phylogeny-aware approach to detect gain and loss
of methylation, reporting an expansion of methylation in mammals with lin-
eage specific properties. Other studies which have focused on characterizing
CREs with histone modifications (Villar et al., 2015) or nascent RNAs (Danko
et al., 2018) in mammals and primates, used heuristic methods to report higher
turnover rates in enhancers than promoters, as well as a wide variety of proper-
ties related to constraint on regulatory architectures. In addition to work char-
acterizing the static landscape of regulatory activity some work has considered
the conservation of dynamic responses in immune induction across the primates
and reported relatively high conservation (Danko et al., 2018). However, it re-
mains unclear how to create a general and robust, yet reasonably simple mod-
eling approach for analyzing comparative epigenetic data.
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In this work, we develop a new framework for analyzing comparative epige-
nomic data and apply it to a subset of histone modification data from Villar
et al. (2015). We report on variety of results comparing the evolution of en-
hancers, promoter, and between subsets of promoters and enhancers based on
characteristics of their associated genes. We also report on potential causes for
discordance between sequence and functional constraint.
3.2 Results
3.2.1 Inferring evolutionary dynamics of epigenetic marks
with a phyloHMM
We developed a phylogenetic hidden Markov model, epiPhyloHMM, to recon-
struct the evolutionary histories of enhancers and promoters. PhyloHMMs are
hidden Markov models whose hidden states define distinct phylogenetic mod-
els drawn from a finite set, allowing them to jointly consider how substitu-
tions (and gains/losses) occur along branches of the phylogeny, and adjacent
genomic sites (Siepel and Haussler, 2005; Felsenstein and Churchill, 1996). The
epiPhyloHMM model consists of two components: a mixture negative binomial
emission model for ChIP-seq peak calling, and a transition model with probabil-
ities defined by an evolutionary process. Using a phyloHMM to model multi-
species epigenetic data helps address issues caused by gaps in the alignment
and the noisiness from variable quality ChIP-seq data.
The core idea behind epiPhyloHMM is that we can model evolutionary gain
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Figure 3.1: The epiPhylo model (A) State transition diagram of the epiPhylo
model, illustrating the sparse transition between the state with no elements
present in any species and any single state with an element present in one or
more species. The red star indicates the selected state for the focal site illus-
trated in the cartoon data. (B) Example of state calls on real H3K4me3 ChIP-seq
data on a subset of species from Villar et al. (2015).
& loss of epigenomic marks in a manner similar to the classic DNA substitution
models, but handle the spatial distribution of epigenetic marks with an HMM.
This is accomplished by labeling the tips of a phylogenetic tree using a two
character 0/1 (absent/present) model to construct a state space (fig. 3.1) for
the HMM. The probability of each state is then computed using the stationary
probability of the characters on the tree pi1 (pi1 = 1 − pi0), and the turnover rate γ.
In our model γ is the instantaneous rate of a gain or loss under a continuous time
Markov process. To prevent the state space from being exponential (2N) in the
number of species, and thus intractable for explicit calculations using the HMM,
we enumerated only a subset of tip labelings on the tree based on scenarios that
could occur with three or fewer mutations on the tree.
We used epiPhyloHMM to analyze ChIP-seq data, so the noise model for raw
read counts given 0/1 characters at the tips of the tree was a mixture negative
binomial distribution, which has become widely used for modeling the vari-
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ance in sequencing count data (Love et al., 2014; Anders et al., 2013). For the 0
state we used a single component mixture model and three components to han-
dle peaks of different heights for the 1 state. A separate emissions model was
trained in each species using data aligned to a subset of its native genome. Once
the data was lifted over to a central reference genome, the emission model was
augmented with a scale parameter ζ, to accommodate alignment gaps between
species which result in missing data in the frame of the reference genome. The
evolutionary parameters pi0, γ, and the state autocorrelation parameter ρ0, are
then fit using the data mapped to the central reference genome (see Methods).
3.2.2 Simulation Study
To test the power of our model to recover the true peak calls and parameters,
we simulated data under the model used for inference, allowing for all 2N states,
given a variety of genome sizes, phylogenetic trees, and values of the turnover
parameter (γ). We fixed the parameters for the peak calling model to their true
values to isolate the ability of the model to correctly estimate the evolutionary
parameters of interest.
With regard to calling peaks at the species level, we found that epiPhylo per-
formed well by both precision and recall metrics but suffered slightly at higher
turnover rates (fig. 3.2). Model predictions were evaluated on a per-bin basis so
that a prediction was considered a true prediction if the model’s state call for a
bin in a particular species matched that bin’s state in the simulation. Each bin in
a multi-bin element was evaluated separately. Across a broad range of rate pa-
rameters and tree topologies, estimates of γ converged to an inflated, but stable
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Figure 3.2: EpiPhylo performance as a function of rate for simulated data.
(A) Precision of the epiPhylo model based on the number of 250bp bins for
each species with correct state calls across three different trees. (B) Recall of the
epiPhylo model based on the number of 250bp bins for each species with cor-
rect state calls across three different trees. For both calculations, the state that
epiPhylo calls is used to assign active elements across species which are then
compared to the true peaks at the species level. All possible species configu-
rations were simulated, and the epiPhylo model was fit with all configurations
that required three or fewer mutations.
estimate of γ with as little as 250KB when γ was large and as much as 250MB
when γ was small (fig. 3.7). The stationary probability for an absent element
pi1 was systematically underestimated while estimates of the autocorrelation ρ1,
converged to the true values given as little as 2.5MB of data (fig. 3.8-3.9). Sys-
tematic biases in the fitted values of γ and pi1 occur to accommodate due to a
ridge in the likelihood surface (fig. 3.10), however this does not greatly impact
the recovery of true regulatory elements in our simulation.
3.2.3 Decoupling the HMM and phylogenetic models for rigor-
ous hypothesis testing and ancestral reconstruction
Next we became interested in using an evolutionary framework for comparing
turnover rates between groups of elements with different annotations. While
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phyloHMMs are powerful for segmenting the genome, the cost of fitting more
parameters with epiPhyloHMM becomes expensive, and the bias in the param-
eter estimates prevents recovery of the true parameters. To address these issues
we adapted the standard phylogenetic model to accommodate probablistic state
labels on the tips of the tree. Then we used the genomic segmentations provided
by epiPhyloHMM to create a single epigenetic state in each species per contigu-
ous epiPhylo element. First we grouped adjacent bins with the same state, then
computed a joint likelihood across all bins conditioned first on the absent state,
then on the present state. The procedure to test for different rates of turnover
between subgroups of elements is as follows: (1) group epigenetic elements to-
gether by one or more annotations and fit a shared rate across all groups with
all other parameters fit separately for each annotation to represent the null hy-
pothesis of a uniform evolutionary rate across the annotated groups, and (2)
as the alternative hypothesis, we can refit the models with separate rates for
each annotation a ∈ A, then (3) compare the models using a likelihood ratio test.
The alternative models are then nested within the null model by breaking the
symmetry between rate parameters (γ) for all groups of elements and adding
|A| − 1 degrees of freedom. This provides an efficient and rigorous method to
detect differences in turnover rate for disjoint groups of epigenetic marks with
one additional degree of freedom.
Another advantage of using a phylogenetic approach for analyzing epige-
netic data over previous heuristic approaches is the ability to identify gain/loss
events that occur on non-terminal branches of the tree. To accommodate the
probabilistic allele labels computed by epiPhylo, we applied the previously de-
scribed altered phylogenetic model to accommodate probabilistic allele labels
at the tips. To accommodate potential differences in phylogenetic parameters
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Figure 3.3: Distribution of state calls by epiPhyloHMM. (A) The distribution
of state calls from epiPhyloHMM for the H3K4me3 mark. (B) The distribution
of state calls from epiPhyloHMM for the H3K27Ac mark.
between enhancers and promoters we partitioned the sites with an H3K27Ac
mark in one or more species into enhancers and promoters based on proximity
to transcriptional start sites (TSS) in humans (fig. 3.11). We note that due to the
human centric nature of the alignment framework, we tend to observe increas-
ing numbers of losses on branches with a longer time to most recent common
ancestor (TMRCA) with human (fig. 3.12). This provides that caveat that lin-
eage specific rate tests may be unreliable if not constructed carefully.
3.2.4 Promoters show deeper epigenetic conservation than en-
hancers
We ran epiPhyloHMM on previously published comparative H3K4me3 and
H3K27Ac ChIP-seq data from placental mammals, producing a genome wide
segmentation. This analysis produced an average of ~16, 000 and ~47, 000 ele-
ments per species for the H3K4me3 and H3K27Ac mark respectively (fig. 3.13).
The excess of H3K27Ac sites was in line with previous findings as the H3K27Ac
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mark covers both enhancers and promoters while the H3K4me3 mark is more
specific to promoters. The distributions of state assignments were also highly
distinct, with the fully conserved state being the most common for the H3K4me3
mark while being the ninth most common state for the H3K27Ac marks, with a
much lower frequency than most of the single species states. The observation
of lower rates of turnover in enhancers than promoters is in line with previous
literature suggesting that promoters are more deeply conserved than enhancers
(Villar et al., 2015).
To more directly investigate the differences in turnover rate between en-
hancers and promoters we partitioned the sites with an H3K27Ac mark based
on proximity to transcriptional start sites (TSS) in humans as previously de-
scribed (fig. 3.11). We then applied our likelihood ratio framework to derive
rigorous estimates of turnover rate in each group and tested directly for a differ-
ence in rate using a tree based on real divergence times. We estimated a turnover
rate of roughly 0.0075 events/mya for enhancers and 0.0035 events/mya for
promoters (fig. 3.4A). We also estimated the half-life for enhancers and promot-
ers and found that the half life for promoters was 424mya while the half life for
enhancers was 302mya (see Methods). The enhancer half-life estimate is similar
to previous estimate from Villar et al. (2015) of 296mya, however the promoter
estimate is considerably shorter than the previous estimate of 939mya. The dif-
ference in the promoter half-life estimates may be partially explained by the
epiPhyloHMM model being unable to fully accommodate the noisy nature of
the H3K27Ac mark, resulting in an excess of gain/loss events thus increasing
the estimated turnover rate. However, we do not see a similar effect on our es-
timate of enhancer half-life so we cannot easily select one estimate as superior
to the other.
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Figure 3.4: Promoters show greater epigenetic conservation than enhancers.
Rates of turnover inferred for enhancers and promoters using the H3K27Ac
mark on an ultrametric tree with branches scaled by chronological divergence
times (Kumar et al., 2017). Error bars correspond to the maximum likelihood
rate estimate +/− one standard error. The enhancer turnover rate is roughly
twice as high as the promoter rate (p  10−300 via likelihood ratio test).
3.2.5 Pleiotropy and mutational intolerance of associated genes
correlate with CRE turnover
Next, we investigated how tissue specificity of expression and sequence con-
straint of genes affected the turnover of putatively linked CREs. Each enhancer
and promoter was assigned to a single gene based on a combination of distance
based rules. Genes that were in the neighborhood of more than one gene were
excluded from this analysis (fig. 3.11).
First we sought to determine whether stability of gene expression across tis-
sues correlated with promoter turnover rates. Based on GTEx data, we anno-
tated genes as being housekeeping, intermediate, or variable, based on their
expression variance across tissues. Then, using the H3K4me3 mark, we com-
pared the turnover rates of promoters for mean-expression-matched variable
and housekeeping genes, and found that the promoters for housekeeping genes
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turned over at roughly half the rate of genes with variable expression (fig. 3.5A).
This result agrees with previous literature and is consistent with the idea that
highly pleiotropic loci are under stronger constraint than non-pleiotropic loci
(Villar et al., 2015). Notably we do not see any difference in the turnover rate of
putatively linked enhancers (H3K27Ac) of housekeeping and variable genes (fig
.3.15). One possible explanation for this observation is that most housekeeping
genes are primarily regulated by their promoters and any enhancers they do
have tend to be close to the promoter and thus are filtered out or mis-annotated
by our pipeline (Zabidi et al., 2015).
Next we investigated whether the promoter conservation across species was
related to gene intolerance for ultra-rare loss of function (LoF) mutations. Since
ultra-rare variants are almost always only present in single copies, genic intoler-
ance for ultra-rare mutation is a proxy for haploinsufficiency. We compared frac-
tion of elements associated with heterozygous LoF intolerant genes (pLI ≥ 0.9;
Samocha et al. (2014)) to the number of species which had an active element for
both promoters and enhancers (H3K27Ac) based on epiPhylo. We found that
for both enhancers and promoters, being present in more species increased the
chance that the associated gene is intolerant to heterozygous LoF mutations,
although the effect was stronger in promoters than enhancers (fig. 3.5A-B). To-
gether, these results indicate that the turnover rate of both enhancers and pro-
moters decrease as selection on the sequence and pleiotropy of associated genes
increases.
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Figure 3.5: Tissue specificity of gene expression and selection on coding se-
quence correlate with conservation of cis-regulatory elements. (A) Estimated
rates for promoter turnover based on the H3K4me3 mark where associated
genes are classified as being housekeeping or tissue specific and matched for
average expression (p  10−30). (B) Fraction of haploinsufficient genes based
on genewise pLI scores for promoters with the H3K27Ac mark. pLI scores are
a measure of intolerance to rare mutations. A pLI score ≥ 0.9 suggests that a
gene is haploinsufficient. The probability of a gene having a pLI score ≥ 0.9
increases by 1.7% for each additional species the mark is conserved in. (C) Frac-
tion of proximal enhancers with H3K27Ac mark associated with a haploinsuf-
ficient gene (pLI ≥ 0.9). The probability of a gene having a pLI score ≥ 0.9
increases by 1.3% for each additional species the mark is conserved in. Error
bars for (B) and (C) represent the mean +/- one standard error.
3.2.6 Dosage sensitivity causes divergence between sequence
and epigenetic conservation at promoters
Next we sought to investigate directly whether gene dominance affects se-
quence and epigenetic conservation. To get a list of genes with known domi-
nance effects, we used a previously curated list of disease genes that were clas-
sified as having either a dominant or recessive mode of action (Berg et al., 2013;
Blekhman et al., 2008). First we tested whether all disease genes showed a lower
rate of turnover at promoters (H3K27Ac) than non-disease genes and found a
roughly 25% decrease in rate (fig. 3.6A). We tested whether dominance of dis-
ease genes affected turnover rates of H3K27Ac marks at promoters and found
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that it did not (fig. 3.6B), likely because loss of promoter severely decreases, if
not abolishes gene expression which is deleterious in a disease gene. In this line
of reasoning we then theorized that while disease genes are equally intolerant
of whole CRE turnover regardless of dominance status, recessive gene should
tolerate smaller changes of expression while dominant one may not. This is be-
cause dominance status can be thought of as an indicator for dosage sensitivity
as mutations with a recessive mode of action are likely insensitive to halving
the expression of the wild type allele while dominant mutations are likely sen-
sitive. Therefore CREs of genes that are highly dosage sensitive should exhibit
stronger sequence conservation than those that are not, even when controlling
for epigenetic conservation. To assess the strength of selection directly on the
sequence we took the mean 100way-phastCons scores in the same sets of dis-
ease gene associated elements. We found that the promoter sequences of genes
that were highly dosage sensitive (had a dominant mode of action), were under
stronger constraint than those that were not (fig. 3.6C).
Another possible explanation for the observed difference in sequence con-
servation between CREs of dominant and recessive gene is different densities
of regulatory sequence. To rule out this possibility we used putative TFBS an-
notated by the ENSEMBL regulatory build to compare the density of TFBS be-
tween the promoters of disease genes with recessive and dominant mechanisms,
and found no difference (fig. 3.6D). Despite similar TFBS densities, we observed
a decreased density eQTLs in the promoters of dominant disease genes relative
to recessive ones, indicating a depletion of regulatory variants of sufficient effect
size for detection (fig. 3.16). Together, these two lines of evidence suggest that
selection on gene regulation occurs differently at multiple levels, dependent on
the mechanism that mediates the deleterious phenotype.
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Figure 3.6: Promoters of disease associated genes show decreased turnover
rates, but the effect of dominance can only be seen at the sequence, not the
epigenetic level. (A) Comparison of promoter turnover rate between disease
and non-disease associated genes. Promoters are based on the H3K27ac mark
(p  10−30). (B) Comparison of promoter turnover rates (H3K27ac) between
disease genes with dominant vs. recessive mode of action (p = 0.61). (C) Com-
parison of sequence conservation in promoter elements between disease genes
with dominant vs. recessive mode of action (p = 7.9 · 10−8). (D) Percent of
promoter nucleotides covered by TFBS from the ENSEMBL regulatory build for
disease genes with dominant vs. recessive mode of action.
We then sought to test our hypothesis that differential dosage sensitiv-
ity leads to different patterns of sequence and epigenetic conservation on an
orthogonally defined group of genes. Two groups that have been used a
model for differential dosage sensitivity are genes involved in metabolism
(low dosage sensitivity) and transcriptional regulation (high dosage sensitiv-
ity)(Wilkie, 1994; Veitia et al., 2018). We compared the epigenetic turnover rate
of promoters marked with H3K27Ac and found that it turned over slightly more
rapidly for metabolism than transcription genes. This observation suggests that,
unlike with the dominant/recessive disease genes, there are differences in se-
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lection on the whole molecular function, therefore dominance is not the only
differential selection relevant factor(fig. 3.17A). However, once we control for
the number of turnover event at a given site as a proxy for epigenetic constraint,
we see greater selection on the sequence in the promoters of transcription genes
than metabolic genes, in line with expectations of greater dosage sensitivity for
transcription genes (fig. 3.17B). Together, these results suggest that dominance
is one of the factors driving differences between levels of sequence and epige-
netic conservation.
3.3 Discussion
Changes in the activity of cis-regulatory elements which alter gene expression
have been shown to drive phenotypic divergence between species (Prescott
et al., 2015; Wray, 2007). Understanding the observed patterns of turnover and
constraint of CREs is therefore informative for understanding the broader prin-
ciples that govern the evolution of gene expression. The development of tech-
niques such as ChIP-seq, STARR-seq, and various forms of BS-seq, for mea-
suring evidence of regulatory function at the whole-genome level have opened
up new opportunities for understanding the evolution of regulatory elements
(Marinov and Kundaje, 2018; Arnold et al., 2014; Pai et al., 2011). Previous
works have performed heuristic analysis of CRE evolution and gene expres-
sion, finding a positive correlation between the stability of gene expression and
CRE conservation, as well as evidence of enhancer emergence correlating with
adaptation (Berthelot et al., 2018; Villar et al., 2015). There have also been some
model based approaches, focusing on integrating phylogenetic information for
a variety of traits including replication timing and methylation (Yang et al., 2018;
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Qu et al., 2018).
In our work we demonstrate a general framework for inferring relative lev-
els of constraint on regulatory elements using a probabilistic model that inte-
grates uncertainty from the raw data and alignments, then, by pooling infor-
mation across regulatory elements, detects differences in turnover rate. By ap-
plying this framework we recapitulate previous work showing that enhancers
turnover more rapidly than promoters (Villar et al., 2015), although we derive
shorter half-life estimates, probably partially due to the noisy nature of the data.
We also found that stability of gene expression across tissues correlates with
conservation across species for promoters but not enhancers. The positive cor-
relation between promoter conservation and gene expression is in agreement
with previous work which found that conservation of gene expression was ele-
vated in housekeeping genes (Berthelot et al., 2018). There are several possible
technical reasons for the difference between enhancers and genes (e.g. imperfect
enhancer-gene assignment, and noisy data) due to housekeeping genes having
a fundamentally different regulatory architecture than tissue specific genes. For
example, previous work has suggested that enhancers of house-keeping gene
are much more likely to be in the core promoter region or the 5’ UTR, character-
istics that could result in them being labeled promoters under our rules (Zabidi
et al., 2015).
We also find several interesting results from the comparison of sequence and
functional conservation. Our two key results were that (1) promoter and prox-
imal enhancer conservation is higher for haploinsufficient genes and (2) even
among essential genes, haploinsufficient genes show elevated levels of sequence
conservation after controlling for epigenetic conservation. We propose that this
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result is due to sequence and epigenetic conservation being indicators of funda-
mentally different types of constraint. While no essential gene can afford to lose
its promoter (indicated by loss of the epigenetic mark), and thus expression,
it has been well documented that some genes which are less dosage-sensitive
can tolerate more potentially expression altering sequence mutations (Petrovski
et al., 2015). Thus this divergence between epigenetic and sequence constraint
is potentially informative about the mode of selection at that locus.
There are a number of caveats for our work. First, all data is aligned to the
human reference genome and uses human annotations for all analysis. This
strategy creates a reference bias and makes lineage specific tests difficult to per-
form. This limitation may be overcome by using a meta-genome that represents
all genomes equally well, for example by using a slight variant of the HAL for-
mat (Hickey et al., 2013). More broadly, the quality of cross-species alignments
and the systematic biases often present in them (e.g. alignments being better
near genes), require careful consideration when performing analysis. There
is also the noisiness of the data itself, which can seen in the large number of
slightly offset peaks which clearly mark the same regulatory element. In our
analysis we tried to address these concerns to some degree by only performing
tests between elements that were marked with the same histone modification
and therefore had similar noise properties, but this noise still almost certainly
increased our estimates of turnover rate. Errors in the cross-species alignment
and the data combine to make analysis especially difficult in the HMM frame-
work, which requires data features be well aligned. Although we have tried to
address both of these problems they remain in need of further work.
Second, all of our mark annotation and gene assignments are based on dis-
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tance rules with respect to the human TSS annotations. In addition to the previ-
ously discussed reference bias, its is also likely that a significant number of en-
hancers (and to a lesser degree promoters) are mis-assigned. Experimental work
to link enhancers to the correct genes, either via 3D-chromatin capture (Sanyal
et al., 2012; Jin et al., 2013; Mifsud et al., 2015), or large scale genome editing
(Fulco et al., 2016), may address some of these issues although the requirement
to perform such assays across multiple species in well matched tissue samples
may prove difficult.
Third, although histone marks such as H3K27Ac and H3K4me3 are strongly
associated with genomic function, they are noisy, imperfect measures of regula-
tory activity (Benton et al., 2017). Assays that measure genomic function with
improved specificity and and cover a narrower span of DNA should provide
better quantification of CRE evolution and make it easier to link sequence and
functional evolution.
In summation, this work presents a general framework for analyzing epige-
netic traits, and applies that framework to learn features of CRE evolution and
investigate the relationship between sequence and functional evolution. Our
observations are largely qualitatively consistent with previous work and the-
ory (Villar et al., 2015; Petrovski et al., 2015), and provide a way forward for
studying regulatory evolution.
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3.5 Methods
3.5.1 ChIP-seq Data Preparation
All ChIP-seq data obtained from Villar et al. (2015). Reads were then aligned
to their native genomes (Mikkelsen et al., 2007; Consortium, 2002; Peng et al.,
2014; Consortium et al., 2014; Lindblad-Toh et al., 2005, 2011; Consortium, 2004;
Yan et al., 2011) (obtained from the UCSC genome browser) using bowtie2 (v
2.2.9) (Langmead and Salzberg, 2012). Each read is then collapsed to cover the
single base at the center of the read and lifted over to central reference genome
using liftOver (Hinrichs et al., 2006) (currently hg38). The lifted-over reads are
then converted to a bigwig of read coverage. Finally, reads are summed into
bins of 250bp. Regions that were not mappable in any other species besides
human (hg38) were excluded from this analysis, leaving 2.97Gb remaining in
the multiple alignment.
3.5.2 Peak Caller Model
A simpler peak calling HMM is used to pre-fit some values to simplify the latter
fitting of the epiPhyloHMM model. The probability of state p (peak/no-peak)
at bin j is a negative binomial mixture model computed as:
P(x˜ j|µ˜p, γ j, w˜p, θD, s˜) =
∑
m
wm ·∏
r
nbinom
(
x j,r|µp,mγ jsr, f (µp,mγ jsr, θD)
)
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where x˜ j is the read counts for each replicate. The mean for a given state p
and mixture component m is µp,m. Each component m is given weight wm where∑
m wm = 1. Since some sites will not be mappable between genome we introduce
γ j which scales up,m by the fraction of bases in bin j that are mappable between
the native and central reference genome. To account for inter-library differences
in sequencing depth we introduce sr, which is calculated as:
sr =
1
max(~s)
∑
j
x j,r
To account for documented differences in the dispersion of replicates for dif-
ferent mean depths, we subsample the genome to get roughly similar numbers
of low, medium, and high coverage sites, then pre-estimate a mean-dispersion
function using DESEQ2. We then use the parameters of that function θD, to
compute the dispersion for all mixture components m and loci j.
The transition model is a simple two state model with auto-correlation ρA for
the peak state and ρI for the background state.
3.5.3 epiPhyloHMM Model
The epiPhyloHMM model enumerates a finite set of states {s1, ..., sE} at the tips of
the tree based on a fixed maximum number of “mutation” events that partition
the species tree. The emission probability for a given state se at site j is computed
as
∏
t P(x|se,t), the joint probability of tip t in having the label specified by state
se, for all tips t. More explicitly it is written as
P(x˜ j|se, µ˜, γ j, w˜, θD, s˜) =
∏
t
∏
p
[
P(x˜ jt|µ˜pt, γ jt, w˜pt, θD, s˜t)δ(p=se,t)
]
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However, where there is a large alignment gap in a species (set to 5Kb for overall
model fitting), the probability of an active element in that region is forced to 0
for within that species, presuming a deletion.
The transition matrix is parameterized along the diagonal by ρI for the fully
inactive state and ρA for all other states. The probability of entering any other
state from the fully inactive state I is (1− ρI) · P(z). P(z) is the probability of state
z computed by Felsenstein’s algorithm given a set of “base” (peak/no-peak)
frequencies pi and mutation rates γ and normalized by
∑
z,I P(z). The rate of
transitions from any tree with one or more active elements to the fully inactive
state is (1 − ρA). All other elements of the transition matrix are 0, preventing the
direct transition between any two different trees with active elements.
3.5.4 Model fitting
The epiPhyloHMM model is fit in several successive steps for efficiency. First,
the peak calling models are fit separately for each species using the reads
mapped to a subset of the native genome (125Mb) using the L-BFGS-B algo-
rithm. The negative binomial mixture parameters of the peak calling model, w
and µ, are then saved for use in the full epiPhyloHMM model.
The genome is then split into twenty similarly sized chunks, with chunk
break-points determined by long regions where there is no alignment to the
human genome by any other species. Bins with less than 15% of their sequence
aligning to the human genome are treated as missing data on a per species basis.
Then the ρA, ρI , pi0, and γ parameters in the epiPhyloHMM model are fit with the
peak calling parameters held constant using L-BFGS-B. The resulted are then
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cleaned by masking out small element calls caused by peak fragmentation using
the following heuristic.
1. Sets of elements that are only seperated by a single bin (a gap enforced by
model sparsity) are grouped together.
2. A sum of scale factors for over all species for each element in the group is
then computed
3. The element with the greatest alignability to the genome based on the sum
of scale factors is kept
4. Additional elements are kept if their score exceeds a threshold t (t = 16).
5. Regions containing discarded elements are masked by setting their scale
factors to 0.
The model then undergoes a second round of fitting post cleaning. The model
is then re-run genome-wide using the median values of the ρA, ρI , pi0, and γ pa-
rameters to obtain a final set of calls.
3.5.5 Extracting and computing allele probabilities from epi-
Phylo
Histone mark elements were annotated based on the viterbi path from a fitted
epiPhylo model. A single element probability was computed per allele by tak-
ing the product of the allelic probabilities from each bin.
114
3.5.6 Site annotation and gene association for enhancers and
promoters
All distances were based on the Ensembl build 93 (Zerbino et al., 2018), accessed
via BiomaRt (Durinck et al., 2005, 2009). Transcriptional start sites (TSS) for all
transcripts were expanded by +/- 1.5kb and grouped by gene to create a pro-
moter region. H3K4me3 elements that overlapped with only one promoter were
annotated as promoter and associated with that gene. H3K4me3 elements that
overlapped with more than one gene’s promoter were annotated as an unasso-
ciated promoter (promoter UA). H3K4me elements that did not overlap with
any promoters were annotated as unknown (unk).
For H3K27Ac marks the same rules were used to label an elements as pro-
moter or promoter UA. For enhancer annotations the TSS were expanded by
+/- 10kb. H3K27Ac elements that overlapped with only one expanded pro-
moter were annotated as a proximal enhancer (enhancer proximal) and associ-
ated with that gene. H3K27Ac elements that overlapped with more than one
gene’s expanded promoter were annotated as an unassociated proximal en-
hancer (enhancer proximal UA). H3K27Ac elements that did not overlap with
any promoters but were still within 100Kb of a TSS were annotated as distal
enhancers and associated with the closest gene (enhancer distal). H3K27Ac el-
ements that met none of these criteria were labeled as unknown. This scheme is
represented in figure 3.11.
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3.5.7 Ancestral reconstruction with probabalistic alleles and
half life estimation
To perform ancestral reconstruction we implemented a standard phylogenetic
model where the values for alleles at the tips of the tree were P(x|allele state)
instead of the standard 0/1 encoding. We then performed the standard mes-
sage passing algorithm on the phylogeny, then estimated the probabilities of a
state transition on each branch as previously described in Siepel et al.. To make
the values as comparable as possible, we used the H3K27Ac sites annotated
as enhancers and promoters, leaving out the H3K3me3 sites. To estimate half
life, estimated separate scaling factors for the enhancer and promoter trees, then
estimated their respective half-lives adjusting for the stationary distribution as
follows:
t 1
2
=
ln(2)
γ · piP
3.5.8 Enhancer vs. Promoter turnover analysis
All H3K27Ac elements annotated as any type of enhancer or promoter were fit
with the stand alone phylogenetic model, first with a joint turnover rate, then
separately. A p-value was computed using the LRT and confidence intervals are
derived using the Fisher information matrix.
116
3.5.9 Housekeeping Vs. Variable gene analysis
Genes were annotated as house-keeping or variable using the GTEx v7 release
(GTEx Consortium, 2017). The variance across tissues was computed for each
gene then 20% with the smallest variance were annotated as housekeeping and
the 20% largest variable were labeled as variable. The gene sets were then
matched for mean expression across tissues using MatchIt (Ho et al., 2011).
Then, using the H3K4me3 probabilistic alleles, shared and separate rates are
fit for each set of elements on the Timetree and a p-value computed using the
likelihood ratio test. Confidence intervals are derived using the Fisher informa-
tion matrix.
3.5.10 pLI analysis
pLI values were obtained from, ExAC release 1 (ftp://ftp.broadinstitute.
org/pub/ExAC_release/release1/manuscript_data). The number of
species which contain an active element is computed using their assigned state
from the epiPhylo element. The effect of an additional species with an active
element was estimated using linear regression. Error bars were computed us-
ing method of moments estimator for the standard error of p from the binomial
distribution.
3.5.11 Dosage sensitivity gene conservation analysis
Lists of dominant and recessive genes were downloaded from the McArthur lab
GitHub gene lists (https://github.com/macarthur-lab). These list are
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the union of the Berg and Blekhman dominant/recessive lists (Berg et al., 2013;
Blekhman et al., 2008). Any genes that were in both lists were removed from the
analysis. Phylogenetic models with both separate and shared rates were fit to
compare both genes not in the list vs. genes in the list and dominant genes vs.
recessive genes using the promoter associated H3K27Ac elements. H3K27Ac
elements were mapped to grch37 using liftOver (Hinrichs et al., 2006) and mean
100way phastCons scores were calculated bwtool (Pohl and Beato, 2014). TFBS
density was computed using the Ensembl regulatory build for grch37 on the
lifted over elements (Zerbino et al., 2015).
Annotations of genes as “Metabolic” or “Generic Transcription Pathway”
were taken from Reactome 2018 (Fabregat et al., 2016). Genes with only one of
the functional annotations “R-HSA-1430728” or “R-HSA-212436” were selected
for analysis. Both the phylogenetic rate and phastCons analysis were performed
in the same manner as it was for the disease genes.
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3.6 Supplemental figures
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Figure 3.7: Estimates of γ depend on the number of expected substitutions
per site. Raw count data was simulated under the epiPhyloHMM model, with
all possible states being enumerated, for genomic regions of varying size (1,000
sites = 250KB) at varying rates for fixed ρA and piA. epiPhyloHMM converges to
inflated estimates of the correct values given increasing amounts of data, with
convergence occurring more rapidly for scenarios with a greater number of ex-
pected substitutions per site.
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Figure 3.8: Estimates of pi0 are biased by mis-estimates of rate. Raw count
data was simulated under the epiPhyloHMM model, with all possible states
being enumerated, for genomic regions of varying size (1,000 sites = 250KB) at
varying rates for fixed ρA and piA. epiPhyloHMM converges to biased estimates
of the correct values depending on the rate.
120
ll
l
l l l
l l l l l
l
l
l
l
l l l
0.8
3
5
9
1,000 10,000 100,000 1,000,000
0.7
0.8
0.9
0.7
0.8
0.9
0.7
0.8
0.9
Number of sites
In
fe
rr
e
d 
ρ A Rate
1e−07
1e−05
0.001
N
um
ber of Species
Simulated ρA
Figure 3.9: Estimates of ρA converge rapidly to the true value Raw count data
was simulated under the epiPhyloHMM model, with all possible states being
enumerated, for genomic regions of varying size (1,000 sites = 250KB) at varying
rates for fixed ρA and piA. epiPhyloHMM converges to correct estimates of the
true value of ρA.
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Figure 3.10: Example of ridge in log-likelihood surface for fitting epiPhylo
model. Log-likelihood is computed on finite grid of γ and pi0 values with the
auto-correlation parameters (ρ0, ρ1) fixed to the true values of the simulated
data. The blue “X” indicates the true value while the red “X” indicates the MLE
parameter values on the computed landscape.
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Figure 3.11: Annotation scheme for epigenetic elements. All genic distances
and annotations are based on the human genome build GrCH38 (Zerbino et al.,
2018). H3K4me3 elements were annotated as promoters if they were within
+/ − 1.5kbp of a TSS. If they overlapped with TSS(s) for only one gene, they
were associated with that gene. If they overlapped with TSSs from more than
one gene, they were annotated as unassigned promoters. The same rules ap-
ply for annotating H3K27Ac marks as promoters, however there are additional
rules for annotating them as enhancers. If a H3K27Ac element was within
+/ − 10kbp but not within +/ − 1.5kbp of a TSS they were annotated as prox-
imal enhancers and assigned analogously to promoters. If an H3K27Ac mark
was between 10kbp and 100kbp away from the nearest TSS, they were anno-
tated as distal enhancer and assigned to the gene of the nearest TSS. H3K27Ac
elements further away than 100kbp were annotated as unknown.
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Figure 3.12: Ancestral reconstruction of gain/loss events on a rooted tree. Pie
chart area per branch is proportional to the fraction of total enhancer/promoter
state calls undergoing gain or loss. Numbers of gain/loss events were com-
puted from pairwise marginals of the transition matrices on each branch. (A)
Expected numbers of enhancer gains/losses based on H3K27Ac mark. (B) Ex-
pected numbers of promoter gains/losses based on H3K27Ac mark. Sites with
an H3K27Ac mark in one or more species were partitioned into enhancers and
promoters based on proximity to transcriptional start sites (TSS) in humans (fig.
3.11, see Methods).
124
Human
Macaque
Marmoset
Mouse
Rat
Ferret
Dog
Cat
Opossum
0 20000 40000 60000
Number of elements
Human
Macaque
Marmoset
Mouse
Rat
Ferret
Dog
Cat
Opossum
0 5000 10000 15000 20000
Number of elementsB.
A.
Figure 3.13: Number of multi-species epigenetic state calls from epiPhylo
based on viterbi decoding (A) H3K4me3 (B) H3K27Ac
125
05000
10000
15000
pro
mo
ter
pro
mo
ter
_U
A
un
k
siteType
N
um
be
r o
f e
le
m
en
ts
A.
0
25000
50000
75000
100000
en
ha
nc
er_
dis
tal
en
ha
nc
er_
pro
xim
al
en
ha
nc
er_
UA
pro
mo
ter
pro
mo
ter
_U
A
un
k
siteType
N
um
be
r o
f e
le
m
en
ts
B.
0
2500
5000
7500
10000
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40
Number of associations per gene
N
um
be
r o
f G
en
es
siteType
enhancer_distal
enhancer_proximal
promoter
C.
Figure 3.14: Distribution of epigenetic element annotations. (A) Distribution
of annotations for elements with the H3K4me3 mark. (B) Distribution of anno-
tations for elements with the H3K27Ac mark. (C) Distribution of the number
of associations with H3K27Ac active elements per gene. The relative height of
each of the color bars represents the fraction of associations that belong to each
annotation category.
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Figure 3.15: No evidence for differential enhancer turnover rates for house-
keeping vs. highly variably expressed genes(A) Estimated rates for enhancer
turnover based on the H3K27Ac mark where associated genes are classified as
being housekeeping or tissue specific and matched for average expression.
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Figure 3.16: eQTL density is depleted in dosage sensitive genes. eQTL density
based on GTEx (v7) significant eQTLs that intersect with epiPhylo elements.
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Figure 3.17: Comparison of sequence and epigenetic turnover for promoters
(H3K27Ac) associated with metabolism and transcription regulation genes.
(A) Estimated turnover rate for trancription pathway and metabolism genes
(p = 0.0074). (B) Mean phastCons scores in promoters of trancription pathway
and metabolism genes. Notches correspond to 1.58 · IQR/√n corresponding to
roughly a 95% confidence interval for the median.
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CHAPTER 4
CONCLUDING PERSPECTIVE
The three chapters of this thesis represent distinct approaches to understand-
ing the biology of cis-regulation of gene expression. Chapter one analyzes cis-
regulation and gene expression from a global perspective, leveraging transcrip-
tional data to posit specific TFs as dictating particular transcriptional programs
without elucidating upon the mechanism at any individual loci. In contrast,
chapter two focuses on understanding the quantitative architecture of a sin-
gle cis-regulatory locus in a TF agnostic fashion, using gene editing data and
statistical modeling to understand the contribution of individual enhancers to
expression a specific gene. Instead of trying to understand how regulatory re-
sponses occur, chapter three seeks to understand the principles by which cis-
regulatory loci change over time, modeling epigenetic data with phylogenetic
models to compare turnover rates of different groups of CREs. This thesis lever-
ages new experimental techniques to understand how CRE function relates to
gene expression at both very short and very long timescales. By considering
each perspective, this thesis improves the state of knowledge about CREs at
both mechanistic and evolutionary levels by developing statistical methods for
data from modern experimental techniques.
Despite the progress made by recent work, there are still many open ques-
tions which further unifying the mechanistic and evolutionary perspectives on
CREs will allow the field to address. At present, it is still not well understood at
a quantitative level how cis-regulatory architectures evolve. While other work
(Villar et al., 2015; Berthelot et al., 2018; Arnold et al., 2014) and chapter three of
this thesis look at wholesale gain/loss of elements, relatively little has been done
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to assess how the strength of both individual enhancers and whole CRE ensem-
bles evolve in connection with the properties of their associated genes. Some
open questions of interest are: (1) how rapidly does the quantitative strength
of enhancers change between species? (2) under what conditions does synergy
between enhancers evolve? and (3) how do properties of associated genes, like
dosage sensitivity, shape the quantitative evolution of CREs? MPRA assays like
STARR-seq (Arnold et al., 2013) could be used in combination with continu-
ous trait models to address the first question. Detecting synergy would require
a combination of gene editing approaches like those from Shin et al. (2016) and
Hay et al. (2016), and high resolution chromatin conformation capture (Ma et al.,
2017) to associate genes and CREs with candidate loci. Understanding the rela-
tionship of genic properties to CRE evolution could then be done using the data
collected for the first two questions and devising statistical tests similar to those
presented in chapter three.
A second area that warrants considerable investigation is the importance
and prevalence of evolutionary compensation at CREs and the principles that
govern it. Previous work has reported evidence of compensation via transcrip-
tion factor binding site substitution both at individual loci (Hogues et al., 2008)
and at a genomic scale in a small number of species (Khoueiry et al., 2017).
Khoueiry et al. (2017) focused on enhancer sequence evolution as a function
of intrinsic properties of the enhancer itself and found evidence for increased
TFBS sequence turnover in TFBS dense enhancers, consistent with the TF col-
lective model (Spitz and Furlong, 2012). At present I see two major avenues to
further our understanding of evolutionary compensation: (1) investigating how
dosage sensitivity and temporal control of associated genes shapes compensa-
tion of both whole the whole CRE and underlying sequence; and (2) developing
130
methods for detecting compensation without relying upon knowledge of spe-
cific TFBS, thereby sidestepping the need for specific semi-mechanistic models
of CREs. Addressing the first area to some degree is likely possible with exist-
ing datasets, either by comparing evidence of TFBS binding/CRE activity vs.
sequence turnover for subgroups of genes in a manner similar to chapter three
of this work. The second avenue might be addressed by exploiting machine
learning methods which predict CRE function from sequence and using them
to predict the activity trajectories of reconstructed ancestral sequences. These
trajectories could then be compared to a neutral model to detect excesses of
compensatory events.
Both of these areas of inquiry will become more pressing as genomewide
quantitative measures of CRE activity become more common, thus exacerbating
the need to move away from thinking of CREs using simple presence/absence
models.
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